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Chapter I  
 
General Introduction and Objectives of the Thesis 
 
1 GENERAL INTRODUCTION 
 Protein Adsorption to Solid Surfaces and Related Risks 1.1
Adsorption of proteins to solid surfaces is a phenomenon observed in a variety of fields and 
processes. Due to their surface-activity, protein molecules are able to interact with various 
surfaces. The specific properties of protein, surface and the surrounding liquid determine the 
extent to which adsorption may occur. For therapeutic protein formulations, adsorption is a 
critical point during processing, storage, and even during patient administration of the 
finished product. Glass and plastics, two of the most common materials for processing 
materials and storage containers, are well-known to adsorb significant quantities of protein [1-
3]. This may lead to a loss in protein content, especially for low-concentrated protein 
solutions where the relative percentage loss is particularly high. Protein adsorption is a well-
known phenomenon e.g. for insulin [1, 4], secretin [5] and Factor VIII [6]. Handling the loss 
of the biologic in the final dosage form is the main challenge for drug manufacturers. One 
strategy to overcome this problem is the overfilling of containers, either by applying a higher 
filling volume, a higher concentration or both [7]. This allows maintaining the necessary 
dosage after passivation of the surface with the drug product. The disadvantage of this 
strategy is the higher cost, especially for expensive protein based drugs [7]. Optimization of 
the protein formulation in regard to adsorption prevention presents an alternative approach. 
Excipients such as surfactants [2] or carbohydrates [8] may be added to reduce adsorptive 
losses, and the formulation may be adapted in terms of pH value and ionic strength. However, 
these adjustments must not endanger long-term stability and biocompatibility of the 
formulation. Furthermore, the proper selection of containers for processing, transport and 
storage is a possible approach to decrease the loss of protein content or activity due to 
2  Chapter I 
 
adsorption. Various container materials such as glass, plastics, and coated materials are 
offered, but up to now, no material provides universal adsorption prevention for all protein 
drugs. 
Besides the loss of protein, structural alterations in the protein due to adsorption were reported 
[9-11]. Additionally, protein adsorption was observed to potentially initiate protein 
aggregation [12] which poses the risk of immunogenic reactions toward the drug product [13]. 
Thus, investigating the factors influencing protein adsorption and the involved mechanisms is 
important to find suitable approaches for the above mentioned issues. 
 Primary Packaging Materials for Parenteral Drugs 1.2
For parenteral drugs, the primary packaging material has to fulfill higher requirements 
compared to topical or oral drug formulations. The Food and Drug Administration (FDA) of 
the United States of America published a Guidance for Industry concerning “Container 
closure systems for packaging human drugs and biologics" [14]. According to this document, 
suitability of a packaging system comprises the protection of, and compatibility with the 
dosage form, safety and proper performance function. Adsorption of the active drug substance 
and a related potency loss may constitute a compatibility problem if unacceptable quality 
changes take place [14]. Therefore, stability testing is usually performed in the packaging 
system intended for final use. The majority of small volume injectable formulations is stored 
in vials, followed by syringes, ampoules and cartridges, whereas bottles and bags are used for 
larger volumes [15]. Still, one of the most commonly used materials is glass, but also plastic 
vials and different coatings and surface modifications for special applications are available on 
the market. 
1.2.1 Glass 
For parenteral drugs, mainly type I borosilicate glass is used. This glass has a high chemical 
resistance, low leachability and a low thermal expansion coefficient [15], is formable and 
tight toward gases and liquids. Furthermore, the production of glass containers is possible in a 
highly reproducible quality. The thermal stability of this material allows a time and cost 
saving sterilization and depyrogenation by dry heat at high temperatures, which is a major 
advantage compared to plastics such as cyclic olefin copolymers (COC) or polypropylene. 
Although the glass surface is basically chemically resistant, reactions with water, acids and 
alkalines may lead to leaching and extraction of glass components. Borosilicate glass is 
mainly composed of silicone dioxide and boric oxide with low levels of other oxides which 
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are not contributing to network formation, such as sodium and aluminum oxides [15]. At 
acidic conditions, network modifying ions from the glass, e.g. Na+, K+ or Ca+ are exchanged 
against protons from an aqueous solution [16]. This loss of hydronium ions during leaching 
leads to rising pH values in the product solution and potential instabilities of biomolecules. 
Alkaline attack of the glass surface which is also known as etching [17] leads to the 
disintegration of the SiO network and finally to decomposition of the glass [16]. Water leads 
to a leaching of ions and ion exchange between the solution and the glass [16]. Finally, glass 
flaking may occur due to the delamination of glass which is embedded at the inner glass 
surface [15]. These flakes consist of alkali borates which recondensed during the final glass 
preparation after migration to the inner surface and evaporation [15]. This glass instability 
gained considerable attention by the authorities [18] as well as glass container manufacturers 
[19] and caused several product recalls in the last years [20]. Several factors are associated 
with the risk of delamination, some of them presented in an advisory of the US FDA [18]: 
(a) the manufacturing process of vials and canes may strongly influence the glass chemical 
resistance [21]. Vials manufactured by molding show a higher resistance than vials formed 
from glass tubing [17]; (b) alkaline formulations and certain buffers pH ≥ 7, e.g. phosphate, 
citrate or tartrate buffers increase the risk of delamination [15]; (c) long storage times, 
(d) terminal sterilization and (e) surface treatment with sulfate, e.g. ammonium sulfate were 
shown to increase the chance of delamination [17]. Vial forming processes at lower heating 
rate and temperature to reduce the migration of alkali ions to the glass surface are one 
possible approach to generate surfaces with a potentially lower propensity for delamination 
[17]. Furthermore, coating of the inner vial surface with SiO2 can avoid delamination [19]. 
Due to the variety of product formulations and processing conditions, no general test will 
serve for individual risk assessment but container testing and additional container screening 
during stability studies will be necessary [19]. 
1.2.2 Siliconization of Glass 
The use of silicones in pharmaceutical manufacturing as antifoames, tubing material and for 
the siliconization of container surfaces has been well established for many years. Already in 
1949, the siliconization of pharmaceutical containers was patented by Goldman [22]. Coatings 
with silicone provide advantages such as a good drainage of the solution from the vial wall 
and thus a better dosage [23], an easy movement of rubber closures e. g. in feeding machines, 
and reduction of the force for plunger movement in syringes [15]. One of the most common 
silicone fluids applied for the coating of parenteral packaging components is 
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Polydimethylsiloxane (PDMS) (Figure I-1a). Endcapped with a trimethylsiloxy-group, some 
Polydimethylsiloxanes meet the requirements of Dimethicone NF [24], Dimethicone Ph. Eur. 
[25] (Figure I-1b), or the monograph “Silicone oil used as a lubricant” Ph. Eur. [26].  
Mundry summarized the typical steps of a siliconization process and the most important 
influencing factors using silicone oil emulsions [27]: Before siliconization, the containers are 
cleaned by flushing with water for injections and dried with pressurized air. Subsequently, the 
silicone oil emulsion is applied by spraying or flushing. Excess aerosol or emulsion is sucked 
up and the silicone oil is baked in a heating tunnel. This step simultaneously includes the 
sterilization and depyrogenation of the containers. Important variables for this process 
comprise the type of the silicone oil, the concentration and composition of the silicone oil 
emulsion, the temperature and time of the baking step, as well as the glass of the containers. 
In this regard, especially the glass composition and hydrolytic resistance are of importance 
[27]. Instead of spraying of the silicone oil (emulsion), dipping or wiping may also be 
applied [28]. Baking of applied silicone fluid with dry heat removes hydration moisture from 
the surface and ensures a good association of the coating with the substrate surface [28]. 
Applying silicone oil emulsions, heating is necessary to destruct the contained emulsifier and 
thus enable a spreading of the PDMS on the surface [27]. During heat-curing, the emulsifiers 
are removed by pyrolysis or hydrolysis and water evaporates [27]. Trimethylsiloxy-
endblocked PDMS fluids are typically considered chemically inert and stable concerning 
decomposition at temperatures below 150 °C, but certain metals and higher temperatures may 
influence their decomposition and reactivity [28]. Formaldehyde and low-molecular weight 
siloxanes may be generated at > 150 °C when silicone oil is heated to about 200 °C [29]. 
Heat-curing at temperatures below 250 °C for less than 2 h for substrates coated with silicone 
fluids is therefore recommended by some PDMS suppliers to reduce the formation of 
formaldehyde [28], whereas in industrial processes, higher temperatures at reduced baking 
times are applied as well. From a literature review, Mundry concluded that silicone oil 
emulsions and curing temperatures between 300-350 °C for 10-30 min. should be applied to 
obtain optimal siliconization results [27]. Due to the low reactivity of silicones and their 
(a)  (b) 
   
Figure I-1: Chemical structure of (a) polydimethylsiloxane (PDMS) and (b) Dimethicone
(trimethylsiloxy-endcapped PDMS). 
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stability, sterilization by dry heat and steam autoclaving as well as gassing by ethylene oxide 
and radiation in low doses is possible [28]. Using silicone oil coatings implies the risk of 
silicone (micro)droplets in the product solution [15, 30]. In therapeutic protein formulations, 
this may increase the risk of product-droplet interactions [15] and potential protein 
aggregation [31]. Minimizing the applied amount of silicone oil is therefore essential [28]. 
Due to their growing relevance as coated packaging material for injectables, siliconized glass 
vials were chosen for adsorption studies with IgG1 and lysozyme. 
1.2.3 Further Materials, Coatings and Surface Modifications used for 
Parenteral Packaging 
Besides glass vials, plastic vials of cyclic olefins such as cyclic olefin copolymer (COC) and 
cyclic olefin polymer (COP) have been developed for the packaging of injectables [15]. 
Compared to polypropylene and polyethylene, these materials provide advantages like high 
transparency, the absence of extractable metal ions and low levels of organics which may be 
extracted [32]. Although plastic containers exhibit advantages compared to glass vials e.g. a 
resistance to breakage and a reduced release of leachables (for COC and COP) [15], their use 
is not very common. Some reasons are the higher costs of these vials [32] and the challenges 
arising from their transfer into an aseptic environment: In contrast to glass vials which are 
conveyed through a heating tunnel directly into an aseptic area, plastic vials are obtained pre-
sterilized (e.g. by irradiation) and have to be transferred aseptically [15]. Furthermore, the low 
weight of these vials compared to glass vials makes their transport on conveyers and their 
handling difficult, and the potential of product-container interactions over shelf-life periods of 
several years is still rising concerns [15]. 
Another option to improve the properties of the packaging materials is the coating of a glass 
or plastic container. One common coating is the siliconization as presented in section 1.2.2. 
Coating of glass vials with thin layers of SiO2 by Plasma Impulse Chemical Vapor Deposition 
(PICVD) strongly reduces the interaction between the vial surface and the drug [16]. Besides 
these marketed products, there is great effort on the development of further protein repellent 
surface coatings to reduce the adsorption of proteins. Poly- or oligoethylene glycol 
(PEG/OEG)-based coatings are one of the most popular and best investigated coatings [33-
35]. The excellent protein repellent effects of these coatings were ascribed to a steric 
repulsion or excluded volume mechanism [36] or the formation of a structurally stable 
interfacial water layer [34]. Further investigated surface modifications include coatings with 
polyglycerols [37-39], zwitterionic self-assembled monolayers and polymers [40, 41], 
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carbohydrate-derived polymers [42] and dextran [43]. Besides the ability to prevent the 
adsorption of proteins, a variety of other factors decide about the feasibility of a coating for 
industrial primary packaging materials for injectables. These include the possibility for 
sterilization, stability of the coating over 2-3 years, non-toxic properties of the coating and 
low costs [7]. Furthermore, the coating quality must be verifiable to 100% [7]. These 
requirements are met only by a minority of promising coatings. Polyglycerols with different 
side groups constitute a new and innovative coating material. Glass vials coated with these 
materials as a potential candidate were therefore investigated for their adsorption preventing 
properties. 
 Mechanisms and Driving Forces for Protein Adsorption 1.3
Proteins are amphiphilic, surface-active molecules which may adsorb to liquid-gas and solid-
liquid interfaces. The mechanism of protein adsorption to and desorption from a solid surface 
involves several steps, which are schematically depicted in Figure I-2 and were thoroughly 
described by Norde [44]. Convection and diffusion transport the protein from solution toward 
the sorbent surface (1), where the molecules may adsorb (2). The rate constant for this 
deposition is thereby influenced by the surface coverage and any barriers opposing attachment 
e.g. due to electrostatic repulsion. Once the protein attached on the surface, it structurally 
relaxes (3), optimizing its interaction with the surface [44]. Changes in the protein´s 
secondary structure may occur upon adsorption [10, 45]. Finally, adsorbed molecules may 
 
Figure I-2: Schematic process of protein adsorption to a solid surface adapted from 
Norde [44]. The relaxation degree of the adsorbed protein molecules is indicated by the 
asterisks. 
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detach (4) and are transported back toward the solution (5) [44]. Protein adsorption to solid 
surfaces was found to be almost irreversible [46, 47] or only partially reversible [48] upon 
rinsing with buffer. The reversibility of adsorption largely depends on the system studied. 
After desorption from the sorbent surface, the detached molecules may potentially restructure 
to their native state (6) [44]. 
 
At constant pressure p and temperature T, protein adsorption requires a decrease of the 
systems´ Gibbs energy G independent of the adsorption mechanism and kinetics [49]. The 
change of the Gibbs energy G due to the adsorption process can be written as 
∆ G ∆ H T∆ S	 0	
where H and S represent the enthalpy and entropy [44]. Analysis of the adsorption induced 
change in Gibbs energy caused by different interaction types thus represents one possible 
approach to investigate the reasons for protein adsorption [49]. In the following, the most 
important factors determining protein adsorption, (A) electrostatic interactions, (B) hydration 
changes, (C) dispersion interactions and (D) structural rearrangements, will be briefly 
presented. 
 
(A) One important driving force for adsorption is the interaction between electrical double 
layers [44] which is also known as electrostatic interactions. The sorbent surface and the 
protein are usually electrically charged. Coions and counterions surround them in an aqueous 
medium and an electrical double layer is formed from this countercharge and the surface 
charges of protein or sorbent [44]. Upon adsorption, when the protein comes close to the 
surface, a superposition of their electrical double layers takes place and the position of the 
counterions is readjusted [50]. It is clear that this interaction is especially favorable when 
protein and sorbent surface bear net charges of different sign and electrostatically attract each 
other. 
 
(B) Besides electrostatic interactions, changes in the state of hydration may be another driving 
force for adsorption [44]. Major parts of the protein’s outer surface are composed of charged 
and polar protein residues since the solvation of these groups compared to hydrophobic 
protein parts is more easy [51], whereas apolar protein side-chains are by trend buried inside 
the protein molecule [52]. The hydration of surface exposed apolar protein patches can be 
avoided by aggregate formation or adsorption of the protein to a non-aqueous interface, 
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leading to a rise in entropy and thus a lowering of the Gibbs energy [49]. Dehydration of 
hydrophobic protein patches can thus constitute a driving force for protein adsorption. 
According to Norde, ∆adsG by dehydration is higher than by a redistribution of charges for the 
majority of hydrophobic surfaces, which is why adsorption to hydrophobic surfaces can be 
observed for all proteins even when the conditions are electrostatically unfavorable [50]. 
 
(C) Dispersion interactions are another possible driving force for protein adsorption to solid 
surfaces. In materials, intermolecular long-range van der Waals forces emerge from dipole 
interactions and consist of three contributing forces, namely the Keesom force, the London 
force and the Debye force [53]. Except for the Keesom force which can also be repulsive, van 
der Waals forces are attractive [53]. The adsorption induced change in Gibbs energy due to 
dispersion interactions depends on the protein dimensions and the space between sorbent 
surface and protein [44]. 
 
(D) Finally, structural rearrangements of the protein may act as a driving force for adsorption 
[44]. Main parts of a protein´s interior consist of hydrophobic protein parts [51]. Upon contact 
of a protein with a non-aqueous surface, the importance of intramolecular hydrophobic 
interactions, which stabilize α-helices or β-sheets, decreases and apolar patches which were 
previously located inside the protein core may orientate toward the non-aqueous sorbent 
surface [44]. Conformational changes upon adsorption such as decreased α-helical structures 
for BSA [54] or a decreased content of β-sheets combined with increased fractions of random 
coil and α-helices for IgG on a hydrophobic surface were reported [10]. It was postulated that 
an increasing entropy due to structural rearrangements is the main reason for spontaneous 
protein adsorption [55]. 
 Factors Influencing Protein Adsorption 1.4
Protein adsorption to solid sorbent surfaces is a complex process which is mainly determined 
by the properties of the protein and the sorbent surface. For therapeutic proteins, the 
adsorption conditions and the composition of the formulation also play an important role. 
Norde established the classification of proteins according to their structural stability upon 
adsorption to surfaces [56]: “Hard” proteins adsorb only under electrostatically attractive 
conditions to polar surfaces and the structural changes involved are low. “Soft” proteins 
undergo stronger structural changes upon adsorption, potentially with a decrease of ordered 
structures, and the increase in conformational entropy allows adsorption to polar surfaces 
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even under electrostatically adverse conditions. However, this entropy gain by adsorption as a 
driving force applies only for globular proteins, whereas for polymers of loose structures, 
adsorption involves entropy losses [56]. Besides this structural aspect, the adsorption behavior 
of a protein depends on its hydrophilicity or hydrophobicity, and the net charge, which was 
already discussed in the previous chapter. At this point it has to be added that adsorption was 
frequently observed not only at attractive electrostatic, but also at repulsive conditions [57, 
58]. This is where not only the net charge, but also the charge distribution of the components 
becomes important for adsorption. Kamiyama & Israelachvili suggested that the number of 
ionic bonds between discrete, oppositely charged groups on sorbent and adsorbate determines 
adsorption [57]. Furthermore, the protein IEP was found to essentially determine adsorption, 
as for a variety of proteins and sorbent surfaces a rough correspondence with the pH of 
maximum adsorption was found [59-62]. Amongst others, this trend was ascribed to a low 
intermolecular repulsion at the pI and high adsorption rates, not allowing reorientation of the 
molecules [63] and increasing structural perturbations in the molecules away from the pI [62]. 
Besides these aspects, the orientation of the molecules at a surface may be related to the 
adsorbed amount [64]. Furthermore, the sorbent properties such as the hydrophilicity and 
hydrophobicity, the surface charge, density and roughness, or the movement of surface bound 
polymer chains may influence adsorption which will not be further discussed here. 
Besides the two components protein and sorbent surface, the formulation conditions are an 
important factor influencing the adsorption of therapeutically applied proteins. These include 
the pH and ionic strength of the solution, buffer composition, surfactants, polyols and sugars. 
The pH value of a solution determines the net charge of the protein and the sorbent and thus 
the electrostatic attractive or repulsive forces in between the protein molecules and between 
protein and sorbent surface. High salt concentrations may screen these electrostatic 
interactions and thus influence the adsorbed amount [65]. Some surfactants can reduce the 
protein adsorption to surfaces [2, 66] or remove already adsorbed protein [67]. Besides, 
protein adsorption was also shown to be influenced by polyols and sugars [8, 66]. IgG1 
adsorption to siliconized vials was investigated considering these formulation relevant classes 
of excipients.  
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2 OBJECTIVES OF THE THESIS 
The aim of this thesis was to investigate the adsorption of a monoclonal IgG1 antibody and 
the model protein lysozyme to vials as primary packaging material. In this work, the main 
focus was set on siliconized glass vials as commercially used coated vials, on non-coated 
glass vials, and new polyglycerol-coated glass vials which are not yet on the market. The first 
main objective was to investigate the influence of different formulation parameters such as pH 
value, ionic strength, surfactants, sugars and polyols on the adsorption of IgG1 to siliconized 
vials (chapter II). Electrostatic and hydrophobic interactions as driving force were evaluated. 
Furthermore, the protein adsorption during long-term storage over several months was taken 
into account. Finally, the adsorption behavior of the model protein lysozyme onto glass vials 
and siliconized vials was investigated. The second main goal was to evaluate the suitability of 
new polyglycerol coated vials as protein repellent packaging material at different formulation 
conditions considering also different vial sterilization methods and long-term storage 
(chapter III). Finally, the role of the Fc and F(ab´)2 fragment for the adsorption of the IgG1 
antibody should be investigated (chapter IV). The focus was set on the adsorption of the 
separated fragments and a correlation with possible molecular orientations. In summary, this 
thesis should evaluate the main factors influencing the adsorbed protein amount especially of 
IgG1 and the protein repellent potential of different glass coatings.  
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Abstract 
It was the aim of this study to investigate the adsorption of IgG1 and the model protein 
lysozyme to type I borosilicate glass vials and siliconized vials. In detail, the influence of the 
formulation parameters pH value, ionic strength and excipients such as nonionic surfactants, 
sucrose, mannitol and HP-β-CD on the adsorbed amount of IgG1 was determined. The pH-
dependent adsorption trends were attributed to the varying importance of electrostatic and 
hydrophobic interactions as driving forces for adsorption. The influence of these forces was 
evaluated by determining the zeta potential of protein and sorbent surface by electrophoretic 
mobility measurements and the calculation of the charge transfer between the protein-sorbent 
interface and the formulation. Furthermore, IgG1 adsorption during long-term storage of the 
formulation in vials was considered by correlating the protein’s physical and chemical 
stability and the adsorbed amount for up to 6 months. pH- and ionic strength dependence of 
adsorption to glass vials and siliconized vials and the influence of protein and sorbent surface 
charge were further investigated for the model protein lysozyme.  
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1 INTRODUCTION 
Protein adsorption is a common phenomenon in a multitude of different fields in nature and 
plays an important role in many biological processes, but it often causes problems in 
analytical and industrial processes. For pharmaceutical protein formulations, nonspecific 
protein adsorption gives rise to major concerns when the protein drug molecules get in contact 
with process materials such as filters, tubings, bags or the final primary packaging. With more 
than 50% of the market, vials are the most frequently used small volume containers for 
injectable formulations, followed by syringes and cartridges which account for 25-30% of the 
products [1]. Besides unmodified vials, siliconized glass vials play the major roles despite the 
efforts in bringing plastics forward. The lubricating properties of silicone oil are used to 
facilitate manufacturing processes and product functionalities, such as to provide easy 
transport of rubber closures in feeding machines, to reduce the plunger friction in syringes [1], 
to allow complete drainage of a liquid formulation from vials and better dosage [2]. 
Polydimethylsiloxane is the most commonly used silicone oil due to its good wetting 
properties, physicochemical stability and biocompatibility. Nevertheless, an increased 
potential for protein aggregation was found in the presence of silicone oil [3]. A basic 
understanding of the interaction mechanism of proteins with a siliconized surface is therefore 
essential for the use of siliconized containers and the prevention of adverse effects. The 
formulation stability of proteins in presence of silicone oil droplets has been investigated 
frequently, including analysis of protein loss, potentially due to protein adsorption to silicone 
oil droplets, and its reduction by surfactants [4] as well as studies on the influence of buffer 
composition on monomer loss [5]. Protein adsorption to silicone-coated solid surfaces was 
investigated by quartz crystal microbalance in presence of surfactants [6, 7] and varying pH 
and ionic strength [8]. Nevertheless, there are few studies investigating protein adsorption to 
siliconized glass surfaces as present in siliconized syringes or vials. 
In general, the sorbent itself influences the adsorption process by the transfer of ions, by 
overlapping of the electrical double layers of the surface and the adsorbing protein, as well as 
by surface dehydration [9]. As observed for various proteins and surfaces, the electrostatic 
interactions between surface and protein as well as amongst protein molecules and thus 
adsorption are strongly influenced by the formulation pH and ionic strength [8, 10]. 
Consequently, determination of the electrokinetic properties, which allow conclusions about 
the charge state of protein and surface, can be used to interpret and predict the adsorption 
behavior of a protein in terms of electrostatic interactions. Additionally, the effect of ion 
incorporation into the protein-sorbent interface can be investigated by calculation of the 
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charge transfer ∆adsσek between the adsorption layer and the surrounding solution [11] and 
correlated with the adsorption behavior. 
In pharmaceutical protein formulations, polyols and sugars as well as nonionic surfactants are 
typically added to stabilize the protein in solution [12-14]. Furthermore, some surfactants 
were shown to prevent adsorption to solid surfaces [15] and to remove already adsorbed 
protein molecules from various surfaces [16, 17], depending on the properties of the surface, 
the protein, and the surfactant. Finally, the concentration of the surfactant in solution 
influences the adsorbed protein amount [18, 19]. 
This study investigates the adsorption of an IgG1 antibody to siliconized vials and borosilicate 
glass vials as commercially relevant primary packaging materials with focus on the 
formulation parameters pH, ionic strength, nonionic surfactants, polyols and sugars. 
Furthermore, adsorption after long-term storage was investigated. The zeta potential of the 
protein and the siliconized surface and the charge uptake ∆adsσek were determined in 
dependence of the pH and used to interpret the adsorption behavior of IgG1 in terms of 
electrostatic interactions. Additionally, the effect of ionic strength on the protein adsorption 
was investigated and related to the interactions between the surface and the protein and in 
between the protein molecules. Furthermore, the adsorption suppressing effect of two 
formulation relevant nonionic surfactants on siliconized vials was analyzed. Finally, 
determination of an ‘adsorption index’ from protein and buffer contact angles was evaluated 
as a predictive tool for IgG1 adsorption. Besides adsorption experiments with IgG1, the 
adsorption of the model protein lysozyme to borosilicate glass vials and siliconized vials was 
investigated with focus on pH, ionic strength and electrostatic conditions. Thus, the study 
should provide a better mechanistic understanding of protein adsorption on relevant 
pharmaceutical containers and conditions and enable to select the appropriate formulation 
composition to minimize protein adsorption. 
2 MATERIALS AND METHODS 
 Materials 2.1
2.1.1 Chemicals 
NaH2PO4 and sucrose were purchased from Merck Chemicals (Darmstadt, Germany). 
Na2HPO4, sodium-dodecyl sulfate (SDS) and Nile Red were obtained from Sigma-Aldrich 
Chemie GmbH (Munich, Germany). NaCl, NaOH and HCl were purchased from VWR 
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International (Darmstadt, Germany). NaOH used for experiments with lysozyme was from 
AppliChem GmbH (Darmstadt, Germany), polysorbate 80 Ph. Eur. (PS 80) was purchased 
from Caelo (Hilden, Germany) and poloxamer 188 Ph. Eur. (P 188) was from BASF 
(Ludwigshafen, Germany). Dow Corning 365, 35% Dimethicone NF Emulsion 
(polydimethylsiloxane (PDMS)) was from Dow Corning Corp. (MI, USA). D-(+)-Mannitol 
was from Riedel-de-Haen (Honeywell Specialty Chemicals Seelze GmbH, Seelze, Germany) 
and hydroxypropyl-β-cyclodextrin (Cavasol W7 HP Pharma) was obtained from Wacker 
Chemie AG (Burghausen, Germany). 
2.1.2 Protein Formulation 
2.1.2.1 Monoclonal IgG1 
A 2 mg/ml IgG1 antibody solution in 10 mM phosphate buffer containing 145 mM NaCl 
(pH 7.2) was kindly donated by Merck Serono (Darmstadt, Germany). The formulation was 
dialyzed into 10 mM phosphate buffer using a Vivaflow® 50 tangential flow cartridge 
(Sartorius-Stedim Biotech, Goettingen, Germany) with a 30 kDa MWCO polyethersulfone 
membrane and the protein concentration was determined by UV-spectroscopy. Variable ionic 
strengths of the solutions were obtained by adding NaCl, followed by pH adjustment with 
1 M NaOH or HCl. A consistent ionic strength of 170 mM at different solution pH values was 
obtained finally by adding adequate amounts of NaCl to the dialyzed solution. Electrophoretic 
mobility measurements were performed with 6 mg/ml antibody dialyzed into a 10 mM NaCl 
solution. For adsorption of IgG1 onto siliconized glass particles, the concentration of IgG1 
formulated in 10 mM phosphate buffer pH 4-9 was adjusted so that an equilibrium 
concentration of about 2 mg/ml resulted after the adsorption process. Ultrapure water 
(PurelabPlus UV/UF system, ELGA, Celle, Germany) was applied for all buffers and all 
solutions were filtered through a 0.2 µm polyethersulfone membrane filter (Pall GmbH, 
Dreieich, Germany). All excipients and chemicals used were of analytical grade. 
2.1.2.2 Hen Egg White Lysozyme 
Hen egg white lysozyme chloride was purchased as dialyzed, white, amorphous powder from 
Dalian Greensnow Egg Products Development Co., Ltd. (Dalian, China). To remove 
excessive chloride from the powder, the lyophilisate was dissolved and dialyzed against 
10 mM phosphate buffer using Vivaflow® 50 tangential flow cartridges (Sartorius-Stedim 
Biotech, Goettingen, Germany) with a 5 kDa MWCO polyethersulfone membrane. pH and 
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ionic strength adjustments were performed as for IgG1 (section 2.1.2.1). The protein solutions 
were filtered through a 0.2 µm polyethersulfone membrane filter (Pall GmbH, Dreieich, 
Germany) before use. For adsorption experiments on glass particles, the concentration of 
lysozyme formulated in 10 mM PBS pH 4-11 was adjusted so that an equilibrium 
concentration of about 10 mg/ml resulted after the adsorption process. 
2.1.3 Vials and Closure Systems 
Adsorption experiments were performed in pre-siliconized (Dow Corning 365) and baked 2R 
Fiolax® glass vials and non-coated Fiolax® borosilicate glass vials which were kindly 
provided by SCHOTT AG (Mainz, Germany). The vials were washed with ultrapure water of 
80 °C in a vial washing machine FAW 500 (Bausch & Stroebel GmbH & Co. KG, Ilshofen, 
Germany). Siliconized vials were autoclaved at 121 °C, 2 bar for 15 minutes, non-coated 
glass vials were heat sterilized at 250 °C for 1 h. After filling, the vials were closed with 
Fluorotec® stoppers and sealed with Flip-Off® seals (West Pharmaceutical Services, 
Eschweiler, Germany). The inner surface area of a vial covered with protein formulation was 
calculated as 13.4 cm² for a filling volume of 3.5 ml [18]. 
2.1.4 Vial Fragments 
Vial fragments for the contact angle measurements were generated from 6R Fiolax® 
borosilicate glass vials, pre-siliconized (Dow Corning 365) and baked 6R Fiolax® Clear glass 
vials as well as 6R TopLyoTM vials. Siliconized and non-siliconized glass vials were pre-
processed as described in section 2.1.3. TopLyoTM vials were pretreated as bare glass vials. 
Flinders of at least 1 x 1 cm were cut off the cylinder of the vial with a DREMEL® 300 series 
rotary tool (DREMEL Europe, Breda, The Netherlands). The flinders were cleaned from 
adherent glass dust with pressurized air. 
2.1.5 Glass Powder 
Borosilicate glass powder was prepared by shattering Fiolax® glass vials and milling in a 
Pulverisette® 5 laboratory planetary mill (Fritsch GmbH, Idar-Oberstein, Germany). The 
particle fraction ≤ 45 µm was collected by fractionation in a sieve tower. Subsequently, the 
particles were washed with ultrapure water, dried at 90 °C and heat sterilized at 250 °C. 
Particles for experiments with lysozyme were again washed extensively before use until the 
washing media reached a pH of about 7. For electrophoretic mobility measurements, a non-
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sedimenting particle fraction was used that was obtained from the supernatant of a particle 
suspension after 2 h sedimentation. 
For experiments with IgG1, the previously washed and sterilized glass powder was again 
cleaned before use by immersion in 1 M NaOH and subsequent washing in water. 
Subsequently, the particles were heat sterilized at 200 °C for 1 h. For electrophoretic mobility 
measurements, the non-sedimenting glass particle fraction after centrifugation dispersed in 
10 mM NaCl was used. 
2.1.6 Siliconized Glass Powder 
For siliconization, 1 g of glass powder prepared for experiments with IgG1 was incubated 
with 3 ml of a 0.5% PDMS emulsion for 30 min. After evaporation of the fluid at 150 °C the 
powder was cured at 200 °C for 1 h. The fraction ≤ 25 µm was collected and washed by 
suspending and centrifuging in water. For electrophoretic mobility measurements, the non-
sedimenting glass particle fraction after centrifugation dispersed in 10 mM NaCl was used. 
2.1.7 Siliconized and Non-coated Fiolax® Glass Slides 
Coated and non-coated Fiolax® glass slides of the same glass composition as Fiolax® 
borosilicate glass vials with the dimension of 20 x 10 mm were kindly prepared by Schott AG 
(Mainz, Germany). Siliconized slides were obtained by immersion of Fiolax® glass slides in 
Dow Corning 365. 
 Methods 2.2
2.2.1 Adsorption Process 
The adsorption process on vials followed the procedure described by Mathes & Friess [10]. 
The pre-processed 2R vials were filled with 3.5 ml of a 2 mg/ml IgG1 solution or 10 mg/ml 
lysozyme solution, closed, sealed, and incubated at 25 °C for 24 h (n=3). The vials were 
emptied and rinsed four times with the corresponding formulation buffer. For the desorption 
of bound protein, 3.5 ml of 10 mM PBS containing 145 mM NaCl and 0.05% sodium dodecyl 
sulfate (SDS), pH 7.2, were filled into each vial. The vials were closed and stored overnight at 
25 °C. 
For the adsorption of IgG1 to siliconized glass particles, the particles were incubated in 
protein solutions of different pH value for 24 h while gently shaken repeatedly (n=3). After 
centrifugation, the supernatant was removed and the particles were washed four times by 
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resuspending and centrifuging with 10 mM NaCl solution of the same pH as the formulation 
buffer. The non-sedimenting glass particle fraction in the supernatant after centrifugation at 
1000 g for 1 min, dispersed in 10 mM NaCl of the formulation pH, was used for 
electrophoretic mobility measurements. Lysozyme containing particle suspensions were 
repeatedly homogenized on a laboratory vortex mixer during the 24 h incubation time. For 
further processing, the supernatant containing not sedimented particles was collected 2 h after 
the last mixing step. This particle fraction was washed with NaCl solution as described above. 
2.2.2 HP-SEC 
2.2.2.1 Non-native HP-SEC 
Quantitative analysis of the desorbed protein was performed via HP-SEC on an Agilent 1100 
HPLC device with an Agilent 1200 fluorescence detector (Agilent Technologies GmbH, 
Boeblingen, Germany) using a TSKgel SWXL guard column and a 3000SWXL SEC-column 
(Tosoh Bioscience GmbH, Stuttgart, Germany) with a flow rate of 0.75 ml/min for sample 
separation. 400 µl of the protein solution were injected and the intrinsic protein fluorescence 
was detected at λex/λem 280 nm/334 nm. Desorption buffer was used as mobile phase. A 
calibration line of 0.1-10 µg/ml IgG1 or 0.05-20 µg lysozyme, respectively, was included in 
each HPLC batch. Agilent ChemStation Software Rev. B 02.01 was used for manual 
integration of the chromatograms. 
2.2.2.2 Native HP-SEC 
Protein aggregates and fragments in the protein solutions were quantified via HP-SEC 
(equipment see 2.2.2.1) with UV-detection at λex 280 nm. 10 mM PBS containing 145 mM 
NaCl, pH 7.2, served as eluent. Protein aggregates, monomer and fragments were separated 
on a TSKgel SWXL guard column (Tosoh Bioscience GmbH, Stuttgart, Germany) and a 
YMC-Pack Diol-300 SEC-column (YMC Europe GmbH, Dinslaken, Germany) at a flow rate 
of 0.5 ml/min, applying an injection volume of 100 µl with a sample concentration of 
2 mg/ml. Agilent ChemStation Software Rev. B 02.01 was used for manual integration of the 
chromatograms. The content of monomer, aggregates and fragments was calculated in percent 
of the total protein content of the reference. 
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2.2.3 Surface Tension Measurements 
Surface tension measurements were performed on a Kruess tensiometer K100 MK2 (Kruess 
GmbH, Hamburg, Germany) with a Wilhelmy plate at 25 °C. The critical micelle 
concentration (CMC) was determined by an automatic titration of a concentrated surfactant 
solution in 10 mM PBS pH 7.2 with pure buffer (n=2). The surface tension was measured 
concentration dependent and the CMC was calculated using the Kruess laboratory desk 
software 3.0. Surface tension values for calculation of the adhesion tension were determined 
with a curved Wilhelmy plate. A sample volume of 0.9 ml was filled in a steel vessel and the 
surface tension was recorded for 10 min (n ≥ 2). 
2.2.4 UV-Spectroscopy 
UV-spectroscopy for protein quantification was performed on a NanoDrop 2000 
spectrophotometer (PEQLab Biotechnology GmbH, Erlangen, Germany) at 280 nm, applying 
an extinction coefficient of 1.40 cm²/mg, typical for antibodies. For lysozyme, an extinction 
coefficient of 2.65 cm²/mg was applied [20]. 
2.2.5 Fluorescence Microscopy 
The silicone coating on the glass particles was visualized by fluorescence microscopy 
(Biozero BZ-8000, Keyence GmbH, Neu-Isenburg, Germany). The particles were stained 
with 0.01 mg/ml Nile Red in acetone. Bright view or a TexasRed filter system with λex/λem 
560 nm/630 nm with 10-fold magnification was used to visualize the particle shape or the 
silicone coating, respectively. The exposure time for the fluorescence was set to 1/200 s so 
that fluorescence was only visible for the siliconized glass powder but not for the non-
siliconized reference. 
2.2.6 Electrophoretic Mobility Measurements 
2.2.6.1 Experiments with IgG1 
The electrophoretic mobility of glass particles, siliconized glass particles and IgG1 molecules 
(6 mg/ml) in 10 mM NaCl was determined by dynamic light scattering with a Zetasizer Nano 
ZS (Malvern Instruments GmbH, Herrenberg, Germany). All measurements were performed 
at constantly 50 mV in disposable zeta cells. A viscosity as of water was assumed for the 
solutions. The pH was adjusted automatically by a Malvern MPT-2 autotitrator in a range of 
pH 2-10 with 0.1 M NaOH and 0.1 M HCl. For siliconized and non-coated glass particles 
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with a large ratio of the particle size to the Debye length κ-1, the Helmholtz-Smoluchowski 
equation was applied for computation [21]. The ζ-potential of IgG1 was calculated according 
to the Hueckel approximation for small particles. Values of non-coated glass powder were 
obtained as an average of three measurements per pH value of one sample (n=1). For 
siliconized particles and IgG1, at least two samples with three measurements each per pH 
value were titrated and used for the calculation of the electrokinetic charge density (n=2). Zeta 
potentials of protein-covered siliconized particles were measured directly in 10 mM NaCl 
solutions of defined pH values (n≥2). 
2.2.6.2 Experiments with Lysozyme 
Zeta potential titrations of bare glass particles (n=2) and lysozyme (10 mg/ml) (n=3) in 
10 mM NaCl were determined in a pH range of 2-12 adjusted with 0.25 M NaOH or 0.25 M 
HCl at constantly 50 mV (equipment and calculations compare section 2.2.6.1). The 
electrokinetic mobility of lysozyme-covered glass particles was measured directly in 10 mM 
NaCl solutions of defined pH values at 150 mV (n=3). 
2.2.7 Streaming Potential Measurements 
Streaming potential measurements were performed on a SurPASS Electrokinetic Analyzer 
(Anton Paar GmbH, Graz, Austria) and an adjustable gap cell with planar slides of 
20 x 10 mm. Streaming potentials were measured in 1 mM KCl. Each glass sample was 
titrated in the range from pH 3 to pH 9 with 0.05 M NaOH or HCl, respectively, starting the 
titrations at neutral pH. Values were obtained as an average of four measurements per pH 
value. Zeta potentials were calculated from the measured streaming potentials based on the 
Helmholtz-Smoluchowski equation. 
2.2.8 Contact Angle Measurements 
Contact angles of the protein solutions or buffer on glass flinders were measured with a 
DSA 100 (A. Kruess Optronic GmbH, Hamburg, Germany). The glass fragments were placed 
horizontally on the sample table in a small transparent plastic chamber to avoid evaporation. 
Using a pipette, a 3 µl droplet of the sample solution was carefully placed on the deepest point 
of the curvature of the flinders (n ≥ 3). The droplet was video recorded for 700 seconds at a 
record rate of 0.36 frames per second. Contact angles after 10 min were calculated from the 
videos by manual adjustment of the base line and circle fitting using the Kruess software 
DSA 3. 
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2.2.9 Fluorescence Spectroscopy 
Fluorescence spectra of protein and buffer were recorded with a Varian Cary Eclipse 
fluorescence spectrophotometer (Varian Deutschland GmbH, Darmstadt, Germany) in a 
10 x 10 mm fluorescence quartz cuvette at 25 °C. Extrinsic fluorescence was measured in the 
presence of 5 µM bis-ANS at λex 385 nm and λem 420 – 700 nm. A protein concentration of 
0.05 mg/ml was applied, corresponding to an absorption of 0.07 at the excitation wavelength, 
as an absorption < 0.1 at λex is required to avoid the inner filter effect [22]. Before the 
measurements, the system was blanked with the corresponding buffer solution. Random noise 
of the extrinsic fluorescence spectra was smoothed by moving average through 12 points. 
2.2.10 Light Obscuration 
Subvisible particle analysis was performed via light obscuration with a PAMAS SVSS-35 
(PAMAS GmbH, Rutesheim, Germany). Three fractions of 0.3 ml of each sample with 0.3 ml 
pre-run volume were analyzed [23]. The system was flushed with ultrapure water before each 
measurement until less than 100 particles per ml in total and no particles ≥ 10 µm were 
detected. PAMAS PMA software was used for data analysis and the amount of particles is 
given in cumulative particles per ml protein solution. 
2.2.11 Visible Particle Inspection 
The solutions were inspected visually in front of a dark background and a light source for 
visible particles. 
2.2.12 Turbidity Measurements 
Turbidity of the solutions was measured using a Nephla laboratory turbidimeter (Hach Lange 
GmbH, Düsseldorf, Germany). Light scattering was detected at an angle of 90 ° in turbidity 
glass cuvettes, applying a filling volume of 1.7 ml. Each sample was measured twice after 
rotating the cuvette in the holder. 
2.2.13 Static Light Scattering 
The size distribution of siliconized particle fractions was analyzed on a Horiba LA-950 
system (Retsch Technology GmbH, Haan, Germany) by static light scattering according to the 
Mie Theory. For the measurements, the siliconized glass powder was suspended in 10 mM 
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NaCl solution and the particle size was determined based on particle volume. Data analysis 
and calculations were performed using the LA-950 software. 
2.2.14 Isoelectric Focusing 
The isoelectric point of IgG1 was determined by isoelectric focusing (IEF) using precast 
SERVALYT PRECOTES® 6-9 IEF plates with a thickness of 300 µm. 10 µl per sample with 
a concentration of 0.5 mg/ml adjusted by dilution with ultrapure water and SERVA Liquid 
Mix IEF marker 3-10 (SERVA Electrophoresis GmbH, Heidelberg, Germany) were applied to 
the gel. Electrophoresis was performed at 2000 V and 6 mA at 5 °C. The gels were stained 
with SERVA Blue W (SERVA Electrophoresis GmbH, Heidelberg, Germany). 
2.2.15 Specific Surface Area Analysis 
The specific surface area of the siliconized particles was determined with an Autosorb 1 
system (Quantachrome, GmbH & Co. KG, Odelzhausen). The sample was outgassed for at 
least 15 h at 25 °C before the physisorption of krypton. Specific surface area analysis of non-
siliconized particles used for adsorption experiments with lysozyme was performed by 
nitrogen gas sorption with a NOVA 4000e system (Quantachrome GmbH & Co. KG, 
Odelzhausen). 
2.2.16 Calculation of the Change in Electrokinetic Charge Density 
Derived from the theory of diffuse double layers, the electrokinetic charge density σek of 
siliconized particles, protein molecules and protein covered siliconized particles was 
calculated from the ζ-potential by Eq. (1) [21]: 
σ 8ε εcRT sinh zFζ 2RT⁄        (1) 
εo represents the dielectric permittivity of vacuum and ε the relative dielectric constant of the 
medium. The concentration of the z-z electrolyte is given by c, R is the gas constant, T the 
absolute temperature and F the Faraday constant. For ε a value of water was assumed. 
According to the principle of electroneutrality, the charge uptake ∆adsσek due to adsorption is 
given by Eq. (2) [11, 24]: 
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∆ σ 	σ IgG/silicon. glass) σ silicon. glass) σ IgG1) ∙ Γ ∙ A	 (2) 
σek represents the charge density per unit surface area at the slipping layer of the complex 
IgG1/siliconized glass (IgG1/silicon. glass), of the siliconized glass particles (silicon. glass) or 
the IgG1 molecule (IgG1) in solution [11]. Г equals the mass of IgG1 adsorbed per unit 
surface area and A the surface area per unit mass protein according to Eq. (3) [11]: 
A ∙           (3) 
The term 4πr2 represents the surface area of one IgG1 molecule of approximately 335 nm2 
when a hydrodynamic radius r of 5.16 nm and a spherical shape of the molecules is assumed 
[10]. A molecular weight Mw of 152 kDa for IgG1 was applied and NA equals the Avogadro´s 
number. Values of Г for the calculation of ∆adsσek were taken as an approximation from the 
pH-dependent adsorption at an ionic strength of 40 mM.  
2.2.17 Calculation of the Change in Interfacial Tension 
When a drop of a liquid is placed on a surface, its shape will depend on the properties of the 
liquid, the surface and the surrounding air [25]. The relationship between the contact angle θ 
and the surface tension of the liquid γl, the surface tension of the solid γs and the interfacial 
tension between solid and liquid γsl is described by the equation of Young: 
γ ∙ cos θ γ γ          (4)	
From this equation, the adhesion tension τ of a protein or surfactant solution (index ´) or of 
pure water / saline (index °) can be derived [26]: 
τ γ′ ∙ cos θ          (5) 
τ° γ° ∙ cos θ°         (6) 
Vogler defined the difference in adhesion tension between a protein and its solvent solution 
[τ ´-τ °] as the adsorption index (AI) [26]. 
τ τ° γ ∙ cos θ γ° ∙ cos θ°       (7) 
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For calculation of the adhesion tension and the adsorption index, static contact angles and 
surface tensions after an equilibration time of 10 min were used. 
3 RESULTS AND DISCUSSION 
 IgG1 Adsorption to Type I Borosilicate Glass Vials and Siliconized Vials 3.1
3.1.1 Charge Characterization and Electrostatic Interactions of IgG1 and 
Siliconized Glass 
At first, in order to understand the charge effects on protein adsorption, the zeta potential of 
IgG1 as well as of siliconized and non-coated glass was determined as a function of pH. The 
siliconized particles used for adsorption experiments exhibited a specific surface area of 
0.79 ± 0.012 m²/g as determined by krypton sorption in two independent BET measurements. 
The correlation coefficient of the measurements was R > 0.9978. The silicone coating was 
visualized by staining with Nile Red (Figure II-1a). Static light scattering showed a bimodal 
size-frequency distribution of the siliconized glass powder (Figure II-2a). Although the 
powder had been fractionated through a 25 µm sieve, some oversized particles were found. 
For the electrokinetic mobility measurements, a fraction with particle sizes of largely < 1 µm 
was used (Figure II-2b) (section 2.1.6). 
Electrophoretic mobility measurements were applied for zeta potential measurements of 
solvated IgG1 and suspended silicone-coated and non-coated glass particles. Additionally, 
streaming potential measurements of siliconized and non-coated planar glass slides served as 
(a) (b)
  
Figure II-1: Siliconized glass particles at 10-fold magnification (a) stained with Nile Red 
at λex/λem 560/630 nm and an exposure time of 1/200 s and (b) at bright view. 
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a reference method. For the IgG1 in solution, a titration curve typical for proteins was 
obtained with a pI of 7.8 (Figure II-3a). The PDMS-coated glass particles exhibited a more 
positive zeta potential in the examined pH-range compared to non-coated glass particles.  
Starting at approx. 13 mV at pH 2, the zeta potential of siliconized glass decreased to a pI of 
3.4 and continued to a minimum of about -32 mV at pH 8.4. The non-coated glass particles 
with a pI of less than 2 showed a negative surface charge in the whole pH range between 2 
and 10 due to the dissociation of silanol groups at the glass surface. The zeta potential 
determined from streaming potential measurements for the planar siliconized glass surface 
was qualitatively in good agreement with the data for the siliconized particles. A pI of 3.6 was 
(a) (b) 
 
Figure II-2: Frequency distribution of siliconized particles fractionated through a 25 µm 
sieve (a) and of the non-sedimenting particle fraction (b). 
(a) (b) 
  
Figure II-3: Zeta potential of glass (∆), siliconized glass ( ) and IgG1 (); 
(a)  determined by electrokinetic mobility measurements of coated and non-coated glass 
particles and IgG1 in 10 mM NaCl solution; (b)  determined by streaming potential 
measurements of coated and non-coated planar glass slides in 1 mM KCl solution. 
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determined for siliconized glass slides (Figure II-3b). In the tested pH range of 3 to 9, the pI 
of uncoated glass slides was not reached. With increasing pH, the titration curves reached a 
minimum of about -49 to -52 mV. Discrepancies of the zeta potentials obtained from 
electrophoretic mobility measurements and streaming potential measurements may be due to 
the different measurement techniques and surface morphologies as well as the slightly higher 
electrolyte concentration used for electrophoretic mobility measurements. 
In literature, the pI of silica is found at approx. 2 [10, 27] but may vary in a range between 
pH < 1.5 and approx. 6, depending on the concentration and type of salt in the solution [27, 
28]. In contrast, the pI of pure silicone oil droplets in solution was found near pH 5.0 [29]. 
Song et al. determined the pI of PDMS-coated glass slides in low concentrated NaCl solution 
and phosphate buffer at approximately pH 4.5 - 5 [30] and Roth et al. found a pI of PDMS-
coated silicon wafers at approx. 4 - 4.5 [31]. Thus the pI determined for our PDMS-coated 
glass particles is slightly lower than the pI reported in literature. After silylation of the glass 
surface with PDMS, a small fraction of silanol groups was found remaining at the surface 
[32]. Thus, the dissociation of residual silanol groups and the adsorption of ions from solution 
determine the zeta potential of a PDMS-coated surface. Consequently, the pI of the coated 
surface will be located between the pI of the uncoated surface and of pure silicone oil in 
solution. The lower pI of our siliconized glass surfaces compared to literature indicates that a 
rather thin silicone layer was formed and that a fraction of silanol groups characterizes the 
surface. 
3.1.2 Investigation of Adsorption of IgG1 to Borosilicate Glass and Siliconized 
Glass by Static Contact Angle Measurements 
The adsorption of proteins is influenced by the sorbent surface characteristics such as 
hydrophobicity, electrical state and the specific surface area [24]. Numerous studies showed 
that hydrophobic surfaces in general adsorb more protein than hydrophilic ones [33-36]. 
Several approaches were made to align the protein adsorption to sorbent surface properties, 
e.g. to surface energy [37]. Vogler suggested that the surface energy does not directly control 
the biological response on a surface, but rather the water reactivity and structure which then 
influences reactions such as cell adhesion and protein adsorption [26]. Therefore, he 
correlated an index of solid-liquid interfacial tensions [τ ´-τ °], which quantifies adsorption, to 
the wettability τ ° of a surface and found a linear correlation [26, 38]. According to Vogler´s 
theory of the ‘adsorption map’, values of [τ ´-τ °] > 0 or [τ ´-τ °] ≤ 0 can be assigned to 
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surfaces supporting or repelling adsorption, respectively [26] and the map can be used to 
predict the adsorption behavior on surfaces [38]. 
To evaluate whether the siliconized and the bare glass surface support the adsorption of IgG1 
according to this theory, the adsorption index (AI) [τ ´-τ °] and the adhesion tension τ ° for 
both surfaces was determined for 2 mg/ml IgG1 solutions and the corresponding buffer 
according to Eq. (6) and (7). Measurements were performed with solutions of pH 4 as the 
adsorbed amount and thus the sensitivity of the measurements was expected to be higher than 
at pH 7.2 (Figure II-4a, b). In contrast to Vogler et al. who determined advancing and 
receding contact angles [38], static contact angles were determined in our experimental setup. 
As a compromise between sufficiently long adsorption time and reasonable measurement 
duration, contact angles and surface tensions were recorded 10 min after placing the droplet 
onto the surface. After this time, adsorption reached more than 70% of the plateau value on 
both siliconized and bare glass vials (Figure II-4a, b) so that changes of the contact angle due 
to adsorption could be expected. Figure II-5a shows the adsorption map for IgG1 in 10 mM 
PBS pH 4. The borders of the depicted parallelogram represent the practically possible 
adsorption indices [τ ´-τ °] calculated from the measured surface tension of the protein 
solution and practically (for surfactants) observed maximal possible (θ ´→ 120 °) or minimal 
(θ ´→ 0 °) values of the contact angle of the protein solution [38]. The corresponding τ ° 
values were calculated from the measured surface tension γl° and the theoretical contact angle 
θ ° of the corresponding solvent. The intersecting line indicates the situation of identical 
contact angles of the protein solution and the pure solvent (θ ´= θ °) [38]. For borosilicate 
(a) (b) 
  
Figure II-4: Adsorption kinetics of IgG1 to borosilicate glass vials (a) and siliconized 
glass vials (b) at pH 4 ( ) and pH 7.2 (∆); incubation at 25 °C, 2 mg/ml in 10 mM 
phosphate buffer with 170 mM ionic strength (n=3, *n=2). 
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glass vials and siliconized glass vials, the AI was in the negative range slightly above or 
below the (θ ´= θ °) line (Figure II-5b) without a significant difference between the contact 
angles of protein solution and pure solvent. Thus, the contact angle measurements did not 
indicate adsorption. In contrast, the AI of TopLyoTM vials was positive with a significant 
difference between θ ´ and θ ° (p < 0.05). As mentioned above, this may indicate that only the 
TopLyoTM vials were hydrophobic enough to support adsorption. However, significant 
adsorption of IgG1 was found also on siliconized and bare glass vials (Figure II-4a, b). To 
explain this kind of discrepancy, Vogler proposed that on hydrophilic surfaces, adsorption 
occurs rather by association of the solute with an incorporated aqueous layer than by 
physicochemical binding to the surface involving a change of the interfacial tension [26]. 
In conclusion, the prediction of IgG1 adsorption to siliconized and bare glass vials by 
calculation of the adsorption index is not feasible for our experimental setup. A clear 
interpretation of the obtained results depicted in Figure II-5 is difficult due to the high 
standard deviations of the contact angles and thus of τ ° and the AI. This may derive from the 
measurement technique applied for the contact angle measurements. Most surfaces such as 
glass show hysteresis of the contact angles due to roughness and chemical heterogeneities, so 
that advancing as well as receding contact angles are necessary to thoroughly characterize the 
wettability of a solid surface [38]. However, our experimental setup enabled only static 
measurements. The manual application of the droplet on the surface and the curvature of the 
fragment itself may also have influenced the droplet shape. 
(a) (b) 
  
Figure II-5: Adsorption map of IgG1 2 mg/ml in 10 mM phosphate buffer with 170 mM 
ionic strength, pH 4, including TopLyo
TM
 vials, siliconized vials and borosilicate glass 
vials; (a) with adsorption boundaries; (b) enlarged section with calculated values. 
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3.1.3 Influence of Formulation pH and Ionic Strength on IgG1 Adsorption to 
Siliconized Glass Vials 
3.1.3.1 Adsorbed IgG1 Quantity as a Function of pH 
The influence of pH on IgG1 adsorption to siliconized glass vials was investigated between 
pH 2 and 12 (Figure II-6). Adsorption experiments were performed at a concentration of 
2 mg/ml IgG1, at which adsorption plateau values (Гpl) for IgG1 on siliconized vials were 
reached (Figure II-7). The pH-dependent adsorption exhibited a bell-shaped curve as 
commonly found for protein adsorption at solid-liquid interfaces [10, 39, 40] with an 
adsorption maximum at a pH of 4 to 5 with about 5.0-5.2 mg/m² (Figure II-6). A second 
maximum was found around the pI of the protein (7.8) at pH 7 to 9 with adsorption values of 
about 4.5 mg/m². With further increasing pH the adsorption level dropped sharply. At pH 12, 
no adsorption could be detected. Thus, for the IgG1 antibody the adsorption maximum was 
not located at the pI of the protein but at acidic pH conditions. As shown by electrophoretic 
mobility measurements, the pIs of the siliconized surface and the antibody are both located 
within the investigated pH range (Figure II-3a). As a consequence, repulsive or attractive 
electrostatic interactions between the protein and the surface as well as intermolecular 
repulsive forces may contribute to the adsorption process at different pH values. In the pH 
range between the pI of siliconized glass of approx. 3.4 and the pI of the antibody of 
approx. 7.8, protein and sorbent were oppositely charged. At pH 4 to 5 the two partners 
carried substantial charge of similar absolute value but opposite algebraic sign, resulting in a 
strong electrostatic attraction. At lower solution pH, the protein net charge and thus the 
 
Figure II-6: Adsorption of IgG1 to siliconized glass vials depending on formulation pH; 
incubation time 24 h at 25 °C, 2 mg/ml in 10 mM phosphate buffer with 170 mM ionic 
strength (n=3). 
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intermolecular repulsion increased, leading to reduced IgG1 adsorption. Electrostatic 
repulsion between protein and sorbent at pH values below the pI of siliconized glass finally 
resulted in significantly reduced adsorbed amounts. Nevertheless, considerable adsorption 
was still found below pH 3.4 which can be attributed to hydrophobic protein-surface 
interactions. At pH values above the adsorption maximum, the decreased protein charge led to 
reduced adsorption due to the low electrostatic attraction. 
Adsorption maxima at pH values below the pI of the protein were also reported by Salgin et 
al. and Mathes & Friess [10, 41]. In contrast, Norde et al. observed a coincidence of the 
adsorption maximum with the region of the protein pI [42]. It was suggested that structural 
perturbations in the protein molecules lead to reduced adsorbed amounts at pH values away 
from the pI [42, 43]. Furthermore, high adsorbed amounts of IgG around the pI were 
explained by a low intermolecular repulsion and high adsorption rates in this pH region [39]. 
In the mentioned literature studying the pH-dependence of protein adsorption, in most cases a 
single adsorption maximum was observed, e.g. for the adsorption of monoclonal IgG1 to 
hydrophilic borosilicate glass vials [10]. In contrast, the adsorption profile for IgG1 on 
hydrophobic siliconized glass vials showed a second local maximum around the pI of the 
protein at pH 7-9. Due to the low protein charge at this pH, electrostatic interactions with the 
surface contributed only marginally to adsorption. On the other hand, hydrophobic 
interactions with the siliconized surface were increased, and on hydrophobic surfaces, the 
decrease in Gibbs energy due to surface dehydration dominates over the changes by 
electrostatic effects [44]. Therefore, adsorption of proteins to surfaces exhibiting hydrophobic 
domains can be observed in general even when the electrostatic conditions are unfavorable 
 
Figure II-7: Adsorption isotherm of IgG1 at pH 4.0 () and pH 7.2 ( ) on siliconized 
glass vials in 10 mM phosphate buffer with 170 mM ionic strength adjusted with NaCl 
and incubation at 25 °C (n=3). 
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[44]. Thus, the second adsorption maximum supposedly resulted from hydrophobic 
interactions of IgG1 with the hydrophobic siliconized glass surface, whereas the first 
adsorption maximum was driven by the predominance of attractive electrostatic interactions. 
At pH values above 7.8, both the antibody and the surface owned an increasingly negative net 
charge. The growing repulsion in between the protein molecules as well as between protein 
and sorbent led to a sharp drop of the adsorbed amount resulting in less than 0.5 mg/m² IgG1 
at pH 11-12. Similar adsorption trends were also described in literature [45, 46]. Despite 
adverse electrostatic conditions, considerable amounts adsorbed, potentially due to the 
transfer of ions between the protein-sorbent interface and the solution [47]. Furthermore, a 
decrease in Gibbs energy by the dehydration of hydrophobic surface patches due to protein 
adsorption [48] or structural rearrangements of the protein [47] were possible driving forces 
for adsorption. 
3.1.3.2 Influence of Ionic Strength on IgG1 Adsorption 
The contribution of electrostatic interactions to IgG1 adsorption at different pH values was 
further investigated by analyzing the adsorbed amount at different ionic strengths up to 1 M 
adjusted with NaCl. Гpl were determined exemplary at pH 4.0 and 7.2, representing a pH close 
to the adsorption maximum and a common formulation pH in the range of the second 
maximum, respectively (compare section 3.1.3.1). At pH 4.0 an increase of the ionic strength 
up to 1 M resulted in rising adsorption values (Figure II-8) whereas a marginal decrease in 
adsorption was observed at pH 7.2. For the interpretation of the observed trend toward 
electrostatic interactions, the role of ions in the adsorption process has to be considered. At 
 
Figure II-8: Adsorption of IgG1 in dependence of ionic strength at pH 4.0 () and 
7.2 ( ); incubation time 24 h at 25 °C, 2 mg/ml in 10 mM phosphate buffer, ionic 
strength adjusted with NaCl (n=3). 
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high salt concentrations, the screening of intermolecular repulsive forces can increase the 
adsorption whereas the shielding of attractive electrostatic interactions between protein and 
sorbent may reduce the adsorption [46]. Increasing adsorbed amounts with rising ionic 
strength at pH 4.0 thus indicated the shielding of predominantly intermolecular repulsive 
forces that limited the packing density on the surface, rather than a screening of electrostatic 
attractive forces. At pH 7.2, the electrostatic attraction toward the hydrophobic surface but 
also the intermolecular repulsion was negligible due to the low net charge of the protein. The 
weak effect of ionic strength on IgG1 adsorption at pH 7.2 thus underlined the minor 
importance of electrostatic interactions for the adsorption process and suggested superiority of 
hydrophobic interactions with the siliconized surface. A similar trend was also found for IgG1 
adsorption to hydrophobic COP plastic vials at pH 7.2 and was ascribed to the predominance 
of dispersion forces and hydrophobic interactions for adsorption and the minor importance of 
electrostatic interactions between the protein molecules [10]. 
In section 3.1.3.1, the pH of maximum adsorption was determined at the basis of an 
adsorption profile at an ionic strength of I = 170 mM and correlated with zeta potential 
measurements performed at much lower ionic strength. However, the ionic strength dependent 
adsorption study showed that predictions of the adsorbed amount at a certain ionic strength 
over a large pH range are difficult. Therefore, the pH-dependent adsorption was additionally 
determined at a lower ionic strength of I = 40 mM to allow a better comparison with results of 
the zeta potential measurements. 
Compared to the adsorption profile obtained at I = 170 mM, the curve at I = 40 mM was 
shifted toward higher pH values in the range of pH 2-7 with the adsorption maximum at 
 
Figure II-9: Adsorption of IgG1 to siliconized glass vials depending on formulation pH
at 40 mM (∆) or 170 mM ( ) ionic strength adjusted with NaCl; incubation time 24 h at 
25 °C, 2 mg/ml in 10 mM phosphate buffer (n=3, *n=2).  
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pH 6-7 instead of pH 4-5 (Figure II-9). At pH values above pHmax, the adsorption curves at 
both ionic strengths virtually matched so that the second maximum observed at I = 170 mM 
was reduced to a shoulder. At pH 12, adsorption could not be quantified anymore. A shift of 
the adsorption maximum toward higher pH values at decreased ionic strength was also 
described for IgG on silica [49, 50] as well as on borosilicate glass vials [10]. The new 
adsorption maximum at pH 6-7 resulted from a charge state of IgG1 allowing sufficient 
attractive electrostatic interactions with the surface but comparably low intermolecular 
repulsion so that a dense occupation of the surface with protein molecules was possible. 
Around the pI of IgG1, the influence of ionic strength on adsorption was low due to the 
dominance of hydrophobic and dispersion interactions with the surface and low 
intermolecular repulsive forces. At acidic pH values, the reduced adsorption at decreased 
ionic strength confirmed the trend observed previously in Figure II-8. 
3.1.4 Electrostatic Interactions within the Adsorption Interface 
When a protein adsorbs to a sorbent, the electrical fields of both components overlap [51]. 
Charge redistribution takes place, which was thoroughly investigated by Norde and Lyklema 
[44, 48]. If the charges of sorbent and protein do not compensate each other, the accumulation 
of net charge in the contact region between both components leads to an energetically 
unfavorable, high electrostatic potential [44]. To prevent such an excess of net charge, an 
exchange of low-molecular-weight-ions between the adsorption layer and the surrounding 
solution may take place [44]. However, the unfavorable chemical effect of the incorporation 
of ions counteracts adsorption [48]. Thus, maximum adsorption affinity is found when no ions 
are additionally incorporated into the contact region [44]. Determination of the pH-dependent 
charge transfer ∆adsσek between the solution and the protein-sorbent interface thus is a helpful 
tool to interpret the location of Гpl(pH)max. ∆adsσek can be calculated from the zeta potentials of 
the protein, the sorbent and the protein-sorbent complex as well as the adsorbed amount per 
unit surface area Гpl(pH) [11] as defined in section 2.2.16, Eq. (2). Zeta potentials of protein 
covered particles were determined in the pH range of 4-9 and compared to that of solvated 
protein and siliconized particles (Figure II-10). The values of the protein-particle complex 
were expected to lie in between the curves of the uncoated particles and the protein due to a 
partial coverage of the negatively charged siliconized surface with positively charged protein 
molecules. In fact, the resulting curve with a pI of 7.7 strongly resembled the curve of the 
protein with a pI of 7.8. The similar pIs of the protein and the protein-covered particles 
indicated a vast compensation of the negative charge of the sorbent surface by adsorbed 
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counterions [11] or by the positive charges of the protein. ∆adsσek was calculated from the zeta 
potentials determined in 10 mM NaCl solutions. Гpl(pH) were taken as an approximation from 
the pH-dependent adsorption at an ionic strength of I = 40 mM (Figure II-9). 
In Figure II-11, ∆adsσek for the adsorption of IgG1 to siliconized glass particles is depicted. 
With increasing pH, the curve rose from negative to positive ∆adsσek values. Intersection with 
the x-axis at approx. pH 7.0 indicated energetically favorable adsorption conditions at this pH 
with a minimum incorporation of additional ions into the adsorption layer. Negative values of 
∆adsσek in the pH range from 4.0 to 7.0 indicated an additional uptake of negatively charged 
ions to compensate the positive charges of the adsorbed protein, whereas further cations were 
incorporated above pH 7.0 [11]. If charge neutrality in the interface is assumed to be the 
driving factor for protein adsorption, maximum adsorption affinity for IgG1 adsorption in 
 
Figure II-10: Zeta potential of siliconized glass particles ( ), IgG1 () and siliconized 
particles with adsorbed IgG1 ( ) in 10 mM NaCl solution. 
 
Figure II-11: Charge transfer (∆adsσek) between the adsorbed layer and the surrounding 
liquid; ∆adsσek calculated according to Eq. (2); Гpl(pH) taken from pH-dependent 
adsorption at 40 mM ionic strength. Standard deviations were calculated by applying 
the Gaussian error propagation.  
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10 mM NaCl was expected at pH 7.0. Decreasing the ionic strength from 170 mM to 40 mM 
already shifted the adsorption maximum from pH 4-5 to pH 6-7. Thus, a further shift toward 
pH 7 in 10 mM NaCl solution and a correspondence of the adsorption maximum with 
∆adsσek = 0 may be expected. A correlation of the adsorption maximum at low ionic strength 
with the pH of minimal charge uptake into the protein-sorbent interface was also observed by 
Mathes & Friess [10]. Elgersma reported a coincidence of the adsorption maximum with the 
pI of protein-covered particles for bovine serum albumin on different latices [11], whereas 
Buijs et al. determined the maximum adsorption of F(ab’)2 at pH values between the pI of the 
protein and the protein-particle complex [52]. Thus, a clear correlation between the adsorption 
maximum, the pH of minimal charge uptake and the pI of the protein-sorbent complex was 
not generally found but is a conceivable concept. 
3.1.5 Influence of Non-ionic Surfactants on IgG1 Adsorption 
In the following, the influence of polysorbate 80 (PS 80) and poloxamer 188 (P 188) on IgG1 
adsorption to siliconized and non-siliconized vials at pH 4.0 and 7.2 was investigated. Both 
non-ionic surfactants are approved for parenteral use. As protein stabilization against 
aggregation by surfactants was shown to depend on the molar ratio of surfactant and protein 
[53, 54], the detergents were added to the IgG1 formulation at surfactant:protein molar ratios 
of 1:10 up to a surfactant excess of 1000:1. 
On siliconized glass vials, both surfactants effectively suppressed IgG1 adsorption. At pH 7.2 
(a) (b) 
  
Figure II-12: Influence of polysorbate 80 () and poloxamer 188 ( ) on adsorption of 
IgG1 to siliconized glass vials at pH 7.2 (a) and pH 4.0 (b); 2 mg/ml in 10 mM phosphate 
buffer with 170 mM ionic strength; incubation time 24 h at 25 °C. Values depicted with 
(×) could not be quantified anymore (n=3, *n=2, °n ≥ 1). 
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and molar ratios of 10:1 and higher, adsorption was reduced by at least 95% to values which 
could not be quantified any more (Figure II-12a). In contrast, a molar ratio of 100:1 PS 80 or 
P 188 was necessary at pH 4.0 to reduce adsorption by approx. 83% or 63%, respectively 
(Figure II-12b). No results could be obtained for a molar ratio of 1000:1 P 188 so that the 
maximum effect could not be determined.  
Most nonionic surfactants are supposed to mainly interact with the sorbent surface [55] and 
their adsorption preventing effect was ascribed to the formation of a detergent layer at the 
sorbent surface [16]. However, a direct interaction of nonionic surfactants with specific 
protein sites was observed in some cases [55]. Therefore, an interaction of the nonionic 
surfactants with hydrophobic protein sites may be considered, preventing hydrophobic 
interactions with other proteins [53] or surfaces. Interestingly, low concentrations of P 188 led 
to increased adsorption at pH 4.0. A similar effect was described previously for protein 
adsorption in presence of SDS [56]. The authors related this phenomenon to a binding of the 
surfactant to the protein, leading to an increased adsorption by changes in the protein 
structure, or to an increased hydrophobicity of the protein-surfactant complex. Moreover, it 
was suggested that surfactants at low concentration may increase the surface hydrophobicity 
and thus the protein adsorption [55]. Both mechanisms were assumed to contribute to the 
observed effect on siliconized glass vials. 
At pH 7.2, strong hydrophobic interactions were supposed to dominate adsorption of the 
marginally charged protein to the negatively charged but hydrophobic siliconized glass 
surface (see section 3.1.3.1). Shielding of hydrophobic protein sites and of the sorbent surface 
by nonionic surfactants efficiently reduced the adsorption of IgG1 at this pH. At pH 4.0, the 
adsorption was reduced to a much lower extent than at pH 7.2. This indicated an only 
marginal suppression of the strong electrostatic interactions between protein and sorbent at 
this pH by PS 80 and P 188.  
At pH 7.2, P 188 was found superior to PS 80 in suppressing IgG1 adsorption, whereas the 
inverse trend was observed at pH 4.0. It was shown that the ability of nonionic surfactants to 
prevent protein adsorption decreased with an increased content of hydrophilic domains of the 
detergent [15]. PS 80 with an HLB value of 15 is more hydrophobic than P 188 which 
exhibits an HLB value above 24 (Table II-1). Therefore, PS 80 was expected to interact 
stronger with hydrophobic protein surface residues than P 188 and to suppress adsorption with 
higher efficiency. However this trend was only observed at pH 4.0. Furthermore, PS 80 and 
P 188 exhibit great differences in their critical micelle concentration (CMC). For PS 80, the 
CMC in PBS pH 7.2 was determined at a concentration of 0.0017% (w/v), corresponding to a 
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molar ratio of surfactant:protein of about 1:1 (Table II-2). P 188 exhibits a CMC of 
0.4032-1.0032% in water [57, 58], corresponding to a surfactant:protein ratio higher than 
10:1. Values for the CMC of P 188 were derived from literature as a determination at 25 °C in 
PBS by surface tension measurements was not possible. At pH 7.2, maximum adsorption 
suppression was reached close to the CMC of both surfactants whereas no clear correlation 
was found for adsorption at pH 4.0. Overall, no general correlation was found between the 
CMC and the concentration of maximum adsorption suppression. It also needs to be 
considered that P 188 may show a slower adsorption at the water / silicone oil interface than 
PS 80 due to its lower diffusion coefficient [6]. This makes a faster formation of a detergent 
film at the buffer/vial interface by PS 80 and a superior prevention of IgG1 adsorption 
conceivable. 
Both surfactants were found efficient in suppressing IgG1 adsorption to siliconized glass vials 
at a standard ionic strength of 170 mM. Furthermore, as described in section 3.1.3.2, a 
Table II-1: Surfactant characteristics of polysorbate 80 and poloxamer 188. 
  Polysorbate 80 (PS 80) Poloxamer 188 (P 188) 
aCMC (in % (w/v)) d0.0017±0.00058 e0.4032-1.0032% [57, 58] 
bHLB value 15 [59] > 24 [57, 58] 
cMW (g/mol) 1310 8600 [60] 
acritical micelle concentration (CMC) 
bhydrophilic lipophilic balance (HLB) 
cmolecular weight 
dCMC determined in 10 mM PBS, 145 mM NaCl pH 7.2 at 25 °C 
eCMC determined in water, values derived from literature 
Table II-2: Molar ratios of surfactant and protein and corresponding concentrations in 
percent (w/v). 
Molar ratio 
surfactant:protein
a 
 Corresponding surfactant concentration in percent (w/v)  
 Polysorbate 80 (PS 80) Poloxamer 188 (P 188)  
1:10  0.00017 0.0011  
1:1  0.0017 0.011  
10:1  0.017 0.11  
100:1  0.17 1.1  
1000:1  1.7 11  
aactual molar ratios in experiments may deviate slightly from the theoretical value 
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reduction of the protein adsorption can be reached by adjusting the ionic strength, depending 
on solution pH. Consequently, the effect of PS 80 and P 188 on IgG1 adsorption to siliconized 
vials was additionally investigated at a minimum ionic strength of 17 or 23 mM in 10 mM 
phosphate buffer at pH 4.0 and 7.2, respectively, at a fixed surfactant:protein ratio of 10:1. 
Decreasing the ionic strength at pH 7.2 led to a slight increase of adsorption without 
surfactants as was already discussed in section 3.1.3.2, and also the adsorption suppressing 
effect of PS 80 and P 188 was slightly reduced at low ionic strength (Figure II-13a). At 
pH 4.0, adsorption in surfactant-free solutions was decreased at low ionic strength. This trend 
was also observed in presence of the surfactants and PS 80 probed to be slightly superior to 
P 188 in suppressing adsorption (Figure II-13b). Also at low ionic strength, the adsorption 
reduction by surfactants in percent was stronger at pH 7.2, where hydrophobic interactions 
dominated the adsorption process, than at pH 4.0. Thus, the influence of ionic strength on the 
overall adsorption trend was maintained in presence of the nonionic surfactants and 
adsorption prevention can be enhanced by an appropriate combination of both parameters. 
3.1.6 Influence of Sugars and Polyols on IgG1 Adsorption 
In the previous section, the effect of surfactants on IgG1 adsorption was investigated. Besides 
this group of excipients, sugars and polyols are widely used as nonspecific stabilizers in 
protein pharmaceuticals [14]. Although not typically used to inhibit protein adsorption, a 
(a) (b) 
  
Figure II-13: Effect of variable ionic strength on IgG1 adsorption to siliconized glass 
vials in absence of surfactants ( ) and with additional polysorbate 80 (patterned) or 
poloxamer 188 (grey) at pH 7.2 (a) and pH 4.0 (b); applied surfactant:protein molar 
ratio 10:1; incubation time 24 h at 25 °C, 2 mg/ml in 10 mM phosphate buffer, ionic 
strength adjusted with NaCl; values marked with (×) could not be quantified any more
(n=3, *n=2). 
23 mM 170 mM
0
1
2
3
4
5
6
7
×A
ds
or
be
d 
am
ou
nt
 (
m
g/
m
²)
Ionic strength
*
×
17 mM 170 mM
0
1
2
3
4
5
6
7
A
ds
or
be
d 
am
ou
nt
 (
m
g/
m
²)
Ionic strength
44  Chapter II 
 
benefit by this group of excipients was described under certain conditions [18, 61]. Therefore, 
its effect on the adsorption of IgG1 to siliconized vials was investigated exemplarily with 
sucrose, mannitol and the cyclic oligosaccharide hydroxypropyl-β-cyclodextrin (HP-β-CD). 
In the presence of sugars, proteins are preferentially hydrated [62] due to an increase of the 
water surface tension by the co-solvent [63, 64], and an unfavorable change of the free energy 
takes place [62]. Since this change is greater for the denatured state with its increased surface 
area, the equilibrium in solution is shifted toward the compact native state of the protein [62]. 
Polyols belong to the group of the solvophobic compounds [63]. These increase the 
hydrophobic effect and, compared to pure water, the interaction between solvent and nonpolar 
protein regions becomes even more unfavorable [63]. Thus, thermodynamically unfavorable 
denaturation of a protein involving a pronounced exposure of hydrophobic protein domains 
and an increased contact area between protein and solvent should be opposed by glycerol 
[65]. As for protein-water interfaces, an exclusion of excipients can also be expected for solid 
surfaces [66]. Cyclodextrins (CDs) are commonly used as solubility enhancers [67]. Due to 
their cone like structure with a hydrophobic interior and hydrophilic exterior, CDs are water 
soluble and able to encapsulate whole molecules [67] or parts of bigger guest molecules, such 
as proteins, in their cavity [68]. Until a few years ago, marketed products for parenteral use 
containing CDs contained exclusively low-molecular-weight drugs [69-71]. However, a 
stabilizing effect of some cyclodextrin derivatives against protein aggregation was reported 
[69, 72]. 
The effect of mannitol, sucrose and HP-β-CD on IgG1 adsorption to siliconized vials was 
investigated at pH 7.2 and pH 4.0. Since the efficiency of co-solutes in stabilizing proteins 
was found to depend on their concentration and a minimum concentration of 300 mM was 
suggested necessary for a stabilization [73], all excipients were added to the protein 
formulation in this concentration. At pH 7.2, only HP-β-CD significantly reduced adsorption 
(p < 0.05), whereas almost no effect was observed in presence of mannitol and sucrose 
(Figure II-14). The effect of various sugars and polyols on the adsorption of BSA, lysozyme 
and RNase A to hydrophilic and siliconized SiO2/TiO2-surfaces was thoroughly investigated 
by Wendorf et al. who found decreased adsorbed amounts for most of the tested conditions 
[61]. This trend could not be observed for mannitol and sucrose in our experiment, but our 
results corresponded well with the findings of Mathes for the adsorption of IgG1 to 
borosilicate glass vials [18]. Wendorf et al. attributed the observed effect to the stabilization 
of the native state of the protein on the surface by the excipients, involving a decreased 
propensity for irreversible adsorption and thus lower irreversible adsorbed amounts [61]. The 
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stabilizing effect of sugars and polyols on a high concentrated IgG1 formulation of pH 6 was 
investigated by Matheus [74]. In this study, the chemical stability of the formulation was only 
marginally improved by sucrose and mannitol, which might explain the unchanged adsorption 
of IgG1 to siliconized vials at pH 7.2. 
Since a strong pH-dependence could be observed in previous adsorption experiments, the 
effect of the excipients was additionally investigated at pH 4.0. Both mannitol and sucrose 
increased the adsorbed amount whereas adsorption was almost unchanged with HP-β-CD 
(Figure II-14). On the one hand, the influence of potential sugar adsorption to the surface may 
be considered to explain the observed phenomenon. Binding of carbohydrates to negatively 
charged mica accompanied by a reduction of the long-range electrostatic double-layer force 
and reduced surface charge was shown by Claesson et al. [75]. However, this would result in 
a decreased electrostatic attraction of IgG1 to the surface also at pH 4.0 and thus rather to 
decreased adsorbed amounts. For some polyols and sugars, a slightly increased adsorption of 
IgG1 at low excipient concentrations but reduced adsorption at high concentrations of 1 M 
was also found by Mathes on borosilicate glass vials at pH 4 [18]. In silicone oil-water 
emulsions, a slightly increased protein loss in solution in presence of sucrose was found by 
Ludwig et al., potentially due to an increased adsorption to silicone oil droplets [4]. The 
authors ascribed this to the exclusion of sucrose from the silicone oil-water interface. 
According to Mahler et al., the exclusion of excipients may lead to a stabilization of proteins 
in solution but also to a destabilization of proteins at interfaces [66]. Adsorption in a 
destabilized state may lead to an increased spreading of the molecules on the surface and thus 
reduced adsorbed amounts, but also an enhanced adsorption via surface exposed hydrophobic 
 
Figure II-14: Influence of 300 mM sucrose, mannitol and HP-ß-CD on IgG1 adsorption 
to siliconized glass vials at pH 7.2 (grey) and pH 4.0 (patterned); 2 mg/ml in 10 mM 
phosphate buffer with 170 mM ionic strength; incubation time 24 h at 25 °C (n=3, 
* n=2); reference values as in Figure II-12. 
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patches may be hypothesized. The stabilizing effect of preferential hydration was shown to 
depend on the pH value for some proteins due to changed dimensions of the molecules [62]. 
However, dynamic light scattering measurements revealed only a minor dependence of the 
hydrodynamic diameter of IgG1 on the pH value [18], so that the different adsorption 
behavior at different pH values could rather not be ascribed to this aspect. A decrease of 
intermolecular electrostatic repulsion by the preferential exclusion and thus higher adsorbed 
amounts at pH 4 may just be speculated. 
HP-β-CD significantly reduced adsorption at pH 7.2, but did not affect adsorption at pH 4.0. 
As mentioned above, cyclodextrins may incorporate hydrophobic protein residues in their 
interior. Hydrophobic interactions of the protein with the surface may thus be reduced, 
leading to decreased adsorption values at pH 7.2. Since the influence of HP-β-CD on 
electrostatic interactions is supposed to be low, the main driving force for adsorption at 
pH 4.0 and thus the adsorbed amounts were almost unchanged. In conclusion, several aspects 
might explain the effect of sucrose, mannitol and HP-β-CD on IgG1 adsorption behavior but 
further studies are necessary to investigate and proof the mechanism. 
3.1.7 Long-term Adsorption of IgG1 to Borosilicate Glass Vials and 
Siliconized Glass Vials 
The contact time of pharmaceutical protein formulations with different process materials 
varies between several hours to days until the product is filled into the final primary 
packaging in that it is stored for months or years. Most studies investigating protein 
adsorption comprise only short time intervals of several minutes up to 24 h [33, 76, 77] 
whereas longer time intervals are considered rarely [78, 79]. Therefore, we investigated the 
adsorption of IgG1 to vials for up to 6 months as a relevant storage time for protein 
formulations. The filled vials were stored at 2-8 °C and additionally at 25 °C and 40 °C, 
corresponding to the temperatures for long-term and accelerated stability studies 
recommended by the ICH-guideline Q1A(R2). The adsorbed amount was determined after 
24 h, 7 days, 1, 3 and 6 months. Besides siliconized vials, also type I borosilicate glass vials 
were included in the study to investigate the influence of the sorbent surface and the 
adsorption mechanism on long-term adsorption trends. 
During storage for up to 6 months, adsorption from protein solutions pH 7.2 changed slightly 
at all temperatures on borosilicate and siliconized vials compared to adsorption after 24 h 
(Figure II-15b, Figure II-16b). Marginal changes were also observed for adsorption to 
borosilicate glass vials at pH 8.6 (Figure II-15c) and at pH 4.0, 2-8 °C and 25 °C (Figure 
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II-15a, Figure II-16a). In contrast, an enormous increase in adsorption was observed at pH 4.0 
in vials stored at 40 °C for 6 months (Figure II-15a, Figure II-16a). 
(a) (b) 
 
(c)  
 
Figure II-15: IgG1 adsorption to type I borosilicate glass vials after 6 months storage at 
pH 4.0 (a), pH 7.2 (b) and pH 8.6 (c) at 2-8 °C, 25 °C and 40 °C; 2 mg/ml in 10 mM 
phosphate buffer with 170 mM ionic strength (n=3, *n=2). 
(a) (b) 
  
Figure II-16: IgG1 adsorption to siliconized glass vials after 6 months storage at pH 4.0
(a) and pH 7.2 (b) at 2-8 °C, 25 °C and 40 °C; 2 mg/ml in 10 mM phosphate buffer with 
170 mM ionic strength (n=3). 
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As stated in section 3.1.3.1, pH-dependent variations in the adsorbed amount can be ascribed 
to different driving forces for adsorption. However, the strong increase in adsorption at 
pH 4.0/40 °C was rather not derived only from a different adsorption mechanism than at 
pH 7.2 but instead from protein instability. High temperature or an unsuitable pH value may 
lead to aggregation [80, 81], and also deamidation processes are influenced by these 
parameters [82]. Therefore, the samples after 6 months storage were investigated for potential 
instabilities that may influence the adsorption behavior. 
In all formulations stored at 40 °C but especially at pH 4.0, the HP-SEC monomer content 
was strongly decreased in favor to increased amounts of higher molecular weight aggregates 
and fragments (Figure II-17a, b). Furthermore, the total amount of protein in these samples of 
pH 4.0 was reduced, which can be related to protein particles and insoluble aggregates that 
were too large to be eluted through the column [83]. As SEC is limited to particles of up to 
approx. 0.02 µm [84], light obscuration was applied to detect particles larger than 1 µm. In all 
formulations, the number of particles was increased compared to the reference but was 
extremely high for solutions of pH 4.0/40 °C (Figure II-19a, b). Solutions of pH 7.2 and 8.6 
still met the specifications of Ph. Eur. for subvisible particles in parenteral solutions with less 
than 6000 counts for particles ≥ 10 µm and less than 600 counts ≥ 25 µm per container [85], 
whereas solutions of pH 4.0 partially exceeded this threshold. Additionally, the turbidity of all 
formulations stored at 40 °C was increased (Figure II-19a, b). 
The tertiary structure of the protein was investigated by extrinsic fluorescence measurements 
with bis-ANS. This dye is weakly fluorescent in a polar environment [86] but exhibits a high 
fluorescence accompanied by a blue shift of the emission maximum upon exposure to a non- 
(a) (b) 
  
Figure II-17: Content of monomer, aggregates and fragments of IgG1 solutions stored in 
type I borosilicate glass vials (a) or siliconized glass vials (b) for 6 months (n=3) at 
different temperatures. 
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(a) (b) 
Figure II-18: Extrinsic fluorescence spectra of IgG1 solutions after 6 months storage at 
pH 4.0, pH 7.2, and pH 8.6 in type I borosilicate glass vials (a) and siliconized glass vials 
(b) in presence of 5 µM bis-ANS (n ≥ 2, *n=1); storage temperatures 2-8 °C, 25 °C and 
40 °C; native IgG1 formulated in 170 mM PBS pH 7.2. 
(a) 
 
(b) 
 
Figure II-19: Turbidity and number of particles determined in IgG1 solutions stored in 
type I glass vials (a) and siliconized glass vials (b) for 6 months at different temperatures 
(n=3, *n=2,
×
n=1). 
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polar environment [87] such as hydrophobic protein domains. All formulations of pH 4.0 but 
especially after storage at 40 °C showed a significantly increased fluorescence accompanied 
by a strong shift of the emission maximum toward lower wavelengths (Figure II-18a, b). This 
indicated a pronounced exposure of hydrophobic protein domains toward the solvent. For 
formulations of pH 7.2, only storage at 40 °C led to increased fluorescence, and no significant 
changes were observed for samples at pH 8.6. 
Potential deamidation of glutamine or asparagine residues of the protein was investigated by 
isoelectric focusing. The modification of the amino acid side chains to glutamate and 
aspartate or iso-glutamate and iso-aspartate residues introduces an additional charge on the 
protein [88]. This can be detected by a shift of the pI of the protein toward lower pH values. 
 
Figure II-20: Isoelectric focusing gel in the pH range of 6-9 for the determination of the 
isoelectric point of IgG1 after 6 months storage in borosilicate glass vials and siliconized 
vials at different temperature. Marker bands were assigned to the pH values of (I) 10.7 
(II) 9.5, (III) 8.0, (IV) 7.8, (V) 7.4, (VI) 6.9, (VII) 6.0, (VIII) 5.3 and (IX) 5.2. 
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After 6 months storage, the pI of IgG1 was unchanged in all formulations stored at 2-8 °C 
(Figure II-20). Samples of pH 7.2/40 °C and pH 8.6/25 °C showed a strong shift of the pI 
toward lower pH values. A slight shift at pH 7.2/25 °C was observed for solutions stored in 
siliconized vials. This trend corresponds with findings in literature, where increased 
deamidation of asparagine was found at neutral or basic pH values and increased temperature 
[82]. In formulations of pH 4.0, no change of the protein pI and thus no deamidation occurred 
independent of the storage temperature. 
In general, only slight differences were observed between corresponding formulations stored 
in siliconized or bare glass vials. The increase in adsorption in solutions of pH 4.0/40 °C 
correlated with the extent of particulate formation and unfolding whereas this correlation was 
not this clear at 25 °C and 2-8 °C. Aggregates or monomers with exposed hydrophobic 
surface residues should show an increased adsorption affinity. A changed surface activity of 
protein molecules at elevated temperature and an increased adsorption tendency of the 
denatured molecules was also proposed by Arnebrandt et al. [89]. Furthermore, the adsorption 
of protein clusters even on a surface with pre-adsorbed protein was previously reported by 
Rabe et al. for hydrophobic surfaces [90]. On the other hand, protein aggregation induced by 
interaction of the protein with the sorbent surface was reported in several cases [91, 92]. 
Initial adsorption, nucleation and subsequent formation of larger aggregates was proposed as a 
possible mechanism [91]. However, this probably requires a rather large sorbent surface for 
contact with the protein as this phenomenon was observed only after the addition of non-
proteinogenic particles to the solution [91] and the onset and occurance of aggregation was 
dependent on the particle number and hydrophobicity [92]. In our case, the surface area of 
about 13.4 cm² wetted by the protein solution in a 2R vial was rather small. Furthermore, the 
very similar increase in adsorption at pH 4.0/40 °C on both the hydrophobic siliconized and 
the hydrophilic borosilicate glass surface rather indicates a largely surface-independent 
aggregation process at acidic pH and elevated temperature. At pH 7.2, the increased 
aggregation and unfolding tendency at 40 °C storage could not be clearly correlated with an 
increase in adsorption (Figure II-15b, Figure II-16b). Whether this applied for pH 8.6 could 
not be clarified since the protein stability and adsorption at 40 °C was investigated only up to 
1 month at this pH. Although no considerable difference in formulation stability was observed 
between solutions stored in borosilicate and siliconized glass vials, the influence of the 
temperature on adsorption was slightly different at pH 7.2 (Figure II-15b, Figure II-16b). It 
may be speculated, that different adsorption kinetics on the hydrophobic and the hydrophilic 
surface led to this observation. 
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 Lysozyme Adsorption to Borosilicate Glass Vials and Siliconized Glass 3.2
Vials 
In the previous sections, the adsorption of a monoclonal IgG1 antibody to siliconized vials 
and also borosilicate glass vials was investigated. Since electrostatic interactions and protein 
charge were shown to strongly influence the adsorption behavior, further adsorption 
experiments were performed with a protein with a different isoelectric point. Lysozyme is a 
small, globular protein with a molecular weight of about 14.4-14.6 kDa [47, 93]. It belongs to 
the group of ‘hard’ proteins that have a high structural stability [94] and was shown to adsorb 
to various surfaces by mainly electrostatic and hydrophobic interactions [33, 47, 95]. 
3.2.1 Charge Characterization of Lysozyme and the Glass Surface 
As already performed for monoclonal IgG1 and siliconized particles (compare section 3.1.1), 
the zeta potential of lysozyme and borosilicate glass was determined to investigate the 
influence of electrostatic interactions for adsorption. The borosilicate glass particles had a 
specific surface area of about 0.72 m²/g determined by a BET measurement using nitrogen as 
adsorbing gas. For the electrokinetic mobility measurements, the non-sedimenting particle 
fraction was used. Lysozyme exhibited a typical protein titration curve with an isoelectric 
point at about pH 10.1 (Figure II-21a). In most cases, the pI of lysozyme was reported in a pH 
range of about pH 11.0 to 11.6 [47, 96-98] but also at approx. pH 9 [99]. Thus, the determined 
pI of lysozyme is in the range reported in literature. In addition, the theoretical protein charge 
(a) (b) 
  
Figure II-21: Zeta potential of lysozyme ( ) (n=3) and its theoretical protein charge  
calculated from the protein sequence (dotted line) (a) and zeta potential of borosilicate 
glass particles (n=2) (b); zeta potentials determined by electrophoretic mobility 
measurements in 10 mM NaCl solution. 
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was calculated from the amino acid composition of the protein with the European Molecular 
Biology Open Software Suite (EMBOSS) [100] using the hen egg white lysozyme sequence 
derived from the Research Collaboratory for Structural Bioinformatics (RCSB) protein data 
bank (ID 1LYZ). The calculated curve showed roughly the same trend as the experimentally 
obtained one but exhibited a higher pI at approx. pH 11.1 (Figure II-21a). The borosilicate 
glass surface exhibited a negative zeta potential at pH values above 2.8 (Figure II-21b) due to 
the dissociation of silanol groups. Thus, the lysozyme molecules and the glass surface were 
oppositely charged in the pH range between 2.8 and 10.1. 
3.2.2 Influence of pH on Lysozyme Adsorption 
All experiments were performed at a lysozyme concentration of 10 mg/ml and an adsorption 
time of 24 h, after which equilibrium adsorption conditions were almost reached (Figure 
II-22). At first, the pH-dependent adsorption of lysozyme to borosilicate glass vials was 
investigated (Figure II-23a). A bell-shaped pH-dependency with steadily increasing 
adsorption from pH 2 to 9 was observed, followed by a strong drop of the curve at pH 10. No 
values are depicted for formulations of higher pH values since visible precipitation of the 
protein was observed soon after pH adjustment. 
Between pH 3 and the adsorption maximum at pH 9, lysozyme and the glass surface are 
oppositely charged and thus electrostatically attract each other. With increasing pH, the 
protein charge and thus the electrostatic attraction toward the negatively charged glass surface 
progressively decreased. Concurrently, the electrostatic repulsion between the molecules on 
the surfaces decreased, allowing a denser occupation of the surface. The simultaneous 
increase of adsorption with decreasing protein charge up to pH 9 thus strongly suggests that 
 
Figure II-22: Adsorption kinetics of lysozyme to type I borosilicate glass vials in 10 mM 
phosphate buffer with 170 mM ionic strength; incubation time 24 h at 25 °C (n=3). 
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mainly the intermolecular repulsion on the surface was the limiting factor for lysozyme 
adsorption. According to this concept, high adsorbed amounts were expected at the pI of 
lysozyme, where the intermolecular repulsion is virtually zero. However, the adsorbed 
amount dropped sharply at pH 10. This may indicate that a certain attractive electrostatic 
interaction with the sorbent surface is necessary for pronounced adsorption. In the state of 
zero net charge, adsorption presumably took place mainly due to surface dehydration and 
dispersive interactions with the surface. A similar pH-dependency of lysozyme adsorption 
with adsorption maxima slightly below the pI of the protein was previously reported for 
various sorbent materials [94, 101]. The pH-dependent adsorption behavior of lysozyme was 
ascribed to a decreasing importance of electrostatic interactions for adsorption with increasing 
pH and the strong influence of lateral electrostatic intermolecular repulsion [102]. Vinu et al. 
further underlined the dominance of hydrophobic interactions close to the pI of the protein 
[101]. 
On siliconized glass vials, adsorption was investigated only at exemplary pH values. A similar 
pH-dependence as on bare glass vials was observed with the adsorption maximum at slightly 
lower pH values between 7 and 9 (Figure II-23b). An exact statement is not possible as 
adsorption was tested at larger pH intervals than on borosilicate vials. In section 3.1.1 it was 
shown that also the siliconized surface exhibited a negative surface charge over a large pH 
range. Therefore, similar charge interactions as on borosilicate glass vials were assumed. In 
general, slightly higher adsorption was found on the hydrophobic surface. This was ascribed 
to the increased contribution of hydrophobic interactions on these vials because the 
dehydration of hydrophobic patches due to adsorption is energetically favorable [48]. 
(a) (b) 
 
Figure II-23: Adsorption of lysozyme to type I borosilicate glass vials (a) and siliconized 
glass vials (b) depending on formulation pH in 10 mM PBS with 170 mM ionic strength; 
incubation time 24 h at 25 °C (n=3).  
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In contrast to our findings and those described by van der Veen et al., several publications 
reported a correspondence of the pI with the pH of maximum adsorption for a variety of 
proteins and surfaces [40, 49]. Some explanations for this phenomenon were already given in 
section 3.1.3.1. Van der Veen et al. hypothesized, that the adsorption maximum of lysozyme 
may instead correspond with the pI of the protein/sorbent complex [94]. Such a correlation 
was previously reported in approximation e.g. for BSA on polystyrene particles [11]. Figure 
II-24 depicts the zeta potential of the lysozyme-borosilicate glass complex between pH 4 and 
pH 11. The curve with an isoelectric point at about pH 6.5 is located in between the curves of 
the bare glass particles and the dissolved lysozyme. This indicates that the negative sorbent 
surface charges are partially compensated by the positive charges of the protein and adsorbed 
counterions. However, a correspondence of the pI of the protein-sorbent complex with the 
adsorption maximum was not found. Net charge neutrality of the protein-covered surface does 
thus not explain the location of the adsorption maximum. It may be rather concluded, that the 
adsorption maximum slightly below the protein pI resulted from an equilibrium of low 
intermolecular repulsion and a sufficient electrostatic attraction toward the (siliconized) glass 
surface, potentially with a certain contribution of hydrophobic interactions. 
3.2.3 Influence of Ionic Strength on Lysozyme Adsorption 
To further investigate the influence of intermolecular and protein-sorbent electrostatic 
interactions on lysozyme adsorption, the adsorbed amount at increasing ionic strengths up to 
1 M was determined on borosilicate glass vials. Experiments were performed at exemplary 
pH values of 4.0, 7.2, 9.0 and 10.0, representing adsorption conditions of very high and high 
 
Figure II-24: Zeta potential of borosilicate glass particles ( ) (n=1), lysozyme () and 
borosilicate glass particles with adsorbed lysozyme ( ) (n ≥ 2) in 10 mM NaCl solution. 
2 3 4 5 6 7 8 9 10 11 12
-80
-60
-40
-20
0
20
40
60
10.12.8
Z
et
a 
po
te
nt
ia
l 
(m
V
)
pH
6.5
56  Chapter II 
 
positive protein charge, at the adsorption maximum or close to the pI of lysozyme, 
respectively. 
At pH 4.0, adsorption increased with ionic strength (Figure II-25). Due to the positive protein 
net charge, the lysozyme molecules are electrostatically attracted toward the negatively 
charged glass surface. With increasing ion concentration, this attraction but also the strong 
repulsion between the molecules, which opposes the overall adsorption process, is screened. 
The simultaneous increase of lysozyme adsorption with ionic strength indicates that mainly 
the intermolecular repulsion determined the adsorbed amount of lysozyme to borosilicate 
glass vials at high protein charge, as was already suggested in the previous section. At pH 7.2 
and pH 9.0, where lysozyme was marginally charged, the adsorbed amount decreased with 
increasing ionic strength (Figure II-25). 
This indicates that the shielding effect of ions predominantly reduced attractive electrostatic 
forces between the protein and the glass surface rather than intermolecular repulsive forces at 
these pH values. Close to the pI at pH 10.0, adsorption was assumed to be rather independent 
of electrostatic interactions due to the almost neutral net charge of lysozyme. However, the 
decrease in adsorption with increasing ionic strength indicated the presence of attractive 
electrostatic interactions between the protein and the sorbent. Although exhibiting a neutral 
net charge, a protein molecule may exhibit positively and negatively charged patches on the 
surface. Kamyama & Israelachvili suggested that the adsorption of amphoteric 
polyelectrolytes is determined by the distribution of charges on sorbent surface and polymer 
rather than by the average charge, and by the formation of discrete ionic bonds between 
oppositely charged groups [103]. Similarly, Yadav et al. proposed that attractive protein-
 
Figure II-25: Adsorption of lysozyme in dependence of ionic strength at pH 4.0 (), 
pH 7.2 (■), pH 9.0( ) and pH 10.0 ( ); incubation time 24 h at 25 °C, 10 mg/ml in 
10 mM phosphate buffer, ionic strength adjusted with NaCl (n=3). 
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protein interactions found between overall positively charged monoclonal antibodies resulted 
from the distribution of surface charges [104]. Ionic strength dependent adsorption of 
lysozyme thus showed, that also close to the pI of the molecule, attractive electrostatic 
interactions with the surface influence the adsorbed amount. Decreasing lysozyme adsorption 
in formulations of pH > 5 with increasing ionic strength was also previously reported for 
silica [105], glass particles [106] and SiO2/TiO2 surfaces [107]. This was ascribed to reduced 
electrostatic attractions due to a shielding of lysozyme and sorbent charges [107]. As can be 
observed in Figure II-25, a further increase of the ionic strength from about 0.4 M to 1.0 M 
hardly influenced the adsorbed amount at all tested pH values, indicating that a further 
shielding of electrostatic interactions did not render the adsorption process more favorable. 
In a further step, the influence of ionic strength on the location of the adsorption maximum of 
lysozyme on borosilicate glass vials was investigated. Reduction of the ionic strength from 
170 mM to 40 mM led to a shift of the adsorption maximum from pH 9 to about pH 6 to 7 
(Figure II-26a). In fact, increased adsorbed amounts in the pH range between about 7 and 10 
and a shift of the adsorption maximum toward higher pH values were expected from the 
previously described experiment. A shift of the maximum in this direction had already been 
observed for IgG1 in section 3.1.3.2 and was  reported in literature for lysozyme [94] and 
other proteins [10, 49, 50]. It may be assumed that the adsorption maximum at 40 mM ionic 
strength resulted from a favorable interplay of large enough electrostatic attraction toward the 
surface and sufficiently low intermolecular repulsion. On siliconized vials, Г(pH)max at 
(a) (b) 
  
Figure II-26: Adsorption of lysozyme to type I borosilicate glass vials (a) and siliconized 
glass vials (b) depending on formulation pH at a formulation ionic strength of 
40 mM (∆) or 170 mM ( ) adjusted with NaCl; incubation time 24 h at 25 °C (n=3, 
*n=2). 
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40 mM ionic strength was located approximately at the same or slightly higher pH than at 
170 mM ionic strength, thus confirming the trends reported in literature (Figure II-26b). In 
conclusion, the adsorption maximum on siliconized vials presumably resulted from a very low 
intermolecular repulsion combined with sufficiently high electrostatic attraction toward the 
sorbent surface as suggested for bare glass vials.  
3.2.4 Isotherm Considerations 
One of the most popular methods to describe protein adsorption affinities to surfaces is an 
adsorption isotherm in which the adsorbed amount Γ is plotted against the equilibrium 
concentration ceq. Several mathematical models were developed and are commonly used to 
analyze protein isotherms [108-110]. One of the first approaches which was often used for 
protein isotherm interpretations [111, 112] is the equation of Langmuir [113]: 
Γ   (8) 
Γ represents the adsorbed amount per surface area, Γmax the maximum adsorbed amount and 
ceq the equilibrium concentration of the protein in solution. K is a constant and was e.g. 
interpreted as bonding energy coefficient [113]. Originally developed for the description of 
gas adsorption to solid surfaces [114], the Langmuir equation was mentioned inappropriate to 
describe the adsorption of proteins from solution due to the difference in adsorption 
mechanism for small molecules and macromolecules [115]. Furthermore, the Freundlich 
model was used to describe adsorption isotherms of proteins [116, 117] by the power function 
Γ K ∙ c   (9) 
in which K represents the Freundlich equilibrium constant and n the isotherm power term 
[109]. This model is used in a strictly empirical sense but may be of theoretical interest to 
describe the adsorption to surfaces which are energetically heterogeneous [108]. Finally, the 
Langmuir-Freundlich equation [113] 
Γ   (10) 
considers heterogeneous bonding energies with the bonding energy coefficients following a 
Gaussian-like distribution [113]. Km represents the median binding affinity and n the 
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heterogeneity index [118]. Values of n < 1 apply for heterogeneous materials whereas 
homogeneous materials exhibit a value of n = 1, leading to a reduction of Eq. 10 to the 
Langmuir equation (Eq. 8) [118]. Mathematically equivalent to the Langmuir-Freundlich 
equation is the Hill equation [119]. Assuming a homogeneous surface it allows the 
interpretation of cooperative adsorption processes due to lateral interactions. In this case, the 
parameter n expresses the degree of cooperativity, indicating positive cooperativity for values 
n > 1 [119]. Thus, fitting of adsorption isotherms according to Eq. 10 allows no interpretation 
of the parameter n in terms of surface heterogeneity and adsorption cooperativity at the same 
time under the same assumptions. 
Lysozyme adsorption isotherms were determined in a bulk solution concentration range 
between 0.005 and 2 mg/ml (Figure II-27a) (here mentioned as isotherm I) and between 0.1 
and 20 mg/ml (isotherm II) (Figure II-27b). The isotherms were fitted using the Langmuir, the 
Freundlich, and the Langmuir-Freundlich equation. Obtained values for the parameters are 
listed in Table II-3.  
None of the models clearly fitted adsorption isotherm I best, just the correlation coefficients 
obtained were slightly better for the Langmuir and the Langmuir-Freundlich equation than for 
the Freundlich equation. Transformation of the data by the Scatchard plot (Γ/ceq versus Γ) or 
the semi-reciprocal plot (ceq/Γ versus ceq) [120] did only show a linear trend for the latter 
equation (data not shown). This implies that the assumptions of the Langmuir model, (a) 
(a) (b) 
  
Figure II-27: Adsorption isotherms of lysozyme on borosilicate glass vials at equilibrium 
concentrations in a range of approximately (a) 0.005-2.0 mg/ml and (b) 0.1-20 mg/ml, 
determined at pH 7.2 in 10 mM phosphate buffer with 170 mM ionic strength;
incubation time 24 h at 25 °C (n=3); isotherms were fitted by nonlinear curve 
approximation applying the Langmuir, the Freundlich or the Langmuir-Freundlich 
model. 
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equilibrium between adsorbed and free molecules, (b) monolayer adsorption, (c) energetic 
equivalence of adsorption sites, and (d) the absence of intermolecular interactions [121], are 
not fulfilled for lysozyme adsorption to borosilicate glass vials in the concentration range of 
isotherm I. Luo & Andrade stated that the Langmuir model is not suitable to describe the 
adsorption of proteins and ascribed this to the different adsorption mechanisms of 
macromolecules compared to small molecules: proteins bind via multiple sites, potentially 
irreversibly, and cooperative interactions play a role [115]. Furthermore, most surfaces are 
heterogeneous [115]. Therefore, the isotherm was further interpreted by the results obtained 
from fitting by the Langmuir-Freundlich equation. As mentioned above, the obtained values 
of n < 1 (Table II-3) may indicate heterogeneity of the borosilicate glass surface. 
Interpretation of n according to the Hill equation, assuming a homogeneous surface, did not 
indicate positive cooperativity of lysozyme adsorption. 
In contrast to isotherm I, the isotherm for bulk concentrations between 0.1 and 20 mg/ml 
could not be fitted by the Langmuir-Freundlich equation. Best fits were obtained by the 
Freundlich model (Figure II-27b), which is only used in an empirical sense and reflects a 
continuous increase of the adsorbed amount with the bulk concentration [108]. 
The poor fitting of both isotherms by the Langmuir model may be ascribed to the 
intermolecular interactions between lysozyme molecules as outlined in the previous sections, 
multilayer adsorption or to the phenomena mentioned by Luo & Andrade as stated above. 
Adsorption isotherms exhibiting steps, as observed for isotherm II in the range of about 
1.5-3.5 mg/ml, were previously reported and considered to derive from conformational 
changes of the adsorbed protein molecules [122] or a change in the molecular orientation with 
surface coverage [24]. 
Table II-3: Results of nonlinear curve fitting of adsorption isotherms of lysozyme on 
borosilicate glass vials at pH 7.2 applying different fitting models. 
 Langmuir model 
parameters 
 Freundlich model 
parameters 
 Langmuir-Freundlich 
model parameters 
 
c (bulk) 
(mg/ml) 
Γmax
a 
(mg/m²) 
K
a 
(ml/g) 
 Γmax
a 
(mg/m²) 
n
a  Γmax
a 
(mg/m²) 
n
a Km
a 
(ml/g) 
 
0.005-2  1.26 0.49  0.93 0.05  1.29 0.73 0.65  
0.1-20 2.95 9.84  2.24 0.16  n.a.b n.a.b n.a.b  
aobtained by nonlinear least square fit according to Levenberg-Marquardt algorithm 
bvalues not computable 
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4 CONCLUSION 
IgG1 adsorption to siliconized glass vials was shown to be highly dependent on formulation 
pH and ionic strength. Determination of the charge characteristics of the protein molecules 
and the siliconized glass surface was used to interpret the contribution of electrostatic 
interactions to the adsorption process. Higher amounts of adsorbed protein were found for pH 
values at which opposing charges of the protein and the surface led to attractive electrostatic 
conditions. Calculation of the charge transfer between the protein-sorbent interface and the 
surrounding solution upon adsorption allowed further insight into the electrostatic interactions 
influencing the adsorption process. The pH of maximum adsorption could be correlated to the 
minimal ion uptake into the interfacial region between protein and sorbent surface. 
Electrostatic interactions are thus supposed to govern adsorption at pH values below the pI of 
IgG1. The occurrence of a second local adsorption maximum around the pI of the protein was 
ascribed to a pronounced influence of hydrophobic interactions. This assumption was 
supported by the marginal influence of ionic strength on adsorption at pH 7.2 compared to 
distinct changes in protein adsorption at pH 4.0. Addition of the nonionic surfactants P 188 
and PS 80 resulted in almost complete suppression of adsorption at pH 7.2, and a strong but 
less pronounced effect at pH 4.0. From these results it can be concluded that electrostatic 
interactions contribute substantially to IgG1 adsorption to siliconized glass vials especially at 
acidic pH values. At these conditions, a decrease of the ionic strength is a rather effective 
additional tool to reduce protein adsorption to packaging materials. Close to the protein’s pI, 
additionally hydrophobic interactions drive adsorption to a remarkable extent. Adsorption of 
IgG1 decreased only slightly by the addition of sucrose, mannitol or HP-β-CD or even 
increased. Determination of an ‘adsorption index’ was found to be not suitable to predict the 
adsorption behavior of IgG1 to different vial surfaces with the applied experimental setup. In 
contrast, a clear dependency of the adsorbed amount on the physical and chemical stability of 
the IgG1 solution could be demonstrated by analyzing the adsorption of IgG1 after long-term 
storage of the formulation in siliconized and bare glass vials. 
Investigation of the pH- and ionic strength dependent adsorption of lysozyme as a model 
protein to borosilicate glass vials and siliconized vials showed a strong dependence on lateral 
electrostatic interactions. Adsorption isotherms could be fitted by applying the Langmuir-
Freundlich or the Freundlich model, depending on the investigated concentration range of the 
isotherm. From the adsorption experiments with lysozyme and IgG1 it can be summarized, 
that especially electrostatic interactions strongly contributed to the adsorption behavior of 
both proteins to borosilicate glass vials and siliconized vials. This understanding enables a 
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more rational design of protein formulations to be packaged in (siliconized) vials or prefilled 
syringes.  
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Abstract 
Proteins are surface active molecules which undergo non-specific adsorption when getting in 
contact with surfaces such as the primary packaging material. This process is critical as it may 
cause a loss of protein content or protein aggregation. To prevent unspecific adsorption, 
protein repellent coatings are of high interest. We describe the coating of industrial relevant 
borosilicate glass vials with linear methoxylated polyglycerol, hyperbranched polyglycerol 
and hyperbranched methoxylated polyglycerol. All coatings provide excellent protein 
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repellent effects. The hyperbranched, non-methoxylated coating performed best. The protein 
repellent properties were maintained also after applying industrial relevant sterilization 
methods (≥ 200 °C). Marginal differences in antibody stability between formulations stored in 
bare glass vials and coated vials were detected after 3 months storage; the protein repellent 
effect remained largely stable. 
Here we describe a new material suitable for the coating of primary packaging material of 
proteins which significantly reduces the protein adsorption and, thus, could present an 
interesting new possibility for biomedical applications. 
1 INTRODUCTION 
Therapeutic antibodies are of great relevance for the treatment of various severe diseases such 
as cancer or autoimmune diseases [1]. The adsorption of therapeutic proteins on surfaces e.g. 
in the production line or in the storage containers poses challenges. Possible consequences 
might be the loss of the protein content [2] but also potential protein aggregation [3] 
accompanied by the risk of immunological reactions leading to a reduced therapeutic effect or 
severe adverse effects [4]. 
Consequently, substantial research efforts are made aiming for reduced protein adsorption to 
various materials [5]. In general, protein adsorption is driven by the interaction between 
electrical double layers and changes in the hydration state but also dispersion interactions [6]. 
To a certain extent, the ionic strength or the pH of the protein formulations may be adapted 
and excipients can be added [7]. Nevertheless, the mandatory preservation of the protein 
stability and the necessary physiological acceptability limits such changes [7]. 
Borosilicate glass is still a common material for the primary packaging of parenteral drugs. 
Aiming for increased protein resistance, material surface modifications by chemical strategies 
such as coating with dextran [8], carbohydrate-derived polymers [9], zwitterionic self-
assembled monolayers and polymers [10, 11] have been tested. Chapman et al. mentioned 
several characteristics of functional groups on SAMs that showed good protein repellent 
properties [12]. Besides containing hydrogen bond accepting and polar groups, they do not 
incorporate hydrogen bond donators and they exhibit no net charge [12]. Furthermore, 
flexible aliphatic polyether elements, a branched structure, hydrophilic groups [13] and a 
stable layer of interfacial water [14] were related to a good protein resistance. Poly(ethylene 
glycol) (PEG) and oligo(ethylene glycol) (OEG) exhibit excellent protein repelling effects 
[15, 16] and unify many of those properties. The exact mechanism of the protein repellent 
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effect of PEG is still ambiguous. Currently, steric repulsion due to the polymer chains [17] 
and the ability to strongly bind water in the interface [14] are the favored theories. However, 
the main drawbacks of PEG are its thermal instability at temperatures ≥ 195 °C [13] and its 
sensitivity toward oxidation [18, 19] putting the coating as well as the drug stability at risk. 
Good thermal stability of the coating material is important for pharmaceutical industrial 
applications as basic sterilization processes such as heat sterilization are performed at 
temperatures ≥ 200 °C. Due to these limitations, the search for alternative materials is still 
ongoing. In 2004, monolayers of dendritic polyglycerol (PG) derivatives were described to 
reduce unspecific protein adsorption comparable to PEG [13]. In contrast to PEG, PG exhibits 
higher thermal and oxidative stability [13]. Decomposition of PEG starts at 195 °C whereas 
PG is stable up to 226 °C [13]. Besides dendritic PG structures, chemical modifications such 
as linear poly(methyl glycerol) and linear polyglycerols are also highly effective in terms of 
cell and protein resistance [20]. Nevertheless, until today, the suitability of those promising 
polymers for pharmaceutical industrial applications in terms of protein resistance has not been 
tested.  
In this study, the coating procedure of industrial relevant type I glass vials serving as primary 
packaging material of protein formulations with linear methoxylated (LPG(OMe)), 
hyperbranched (HPG(OH)) and hyperbranched methoxylated (HPG(OMe)) polyglycerol 
based monolayers are described. We investigated the effects on protein adsorption using an 
IgG model antibody and human Growth Hormone (hGH). The impact of pH, ionic strength, 
and the suitability for industry-relevant sterilization methods (heat sterilization and 
autoclaving) on the protein resistance is presented. Furthermore, coating stability, long-term 
storage stability and its influence on the protein structure are described. 
2 MATERIALS AND METHODS 
 Chemicals 2.1
All chemicals and solvents were reagent or HPLC grade, used as received and purchased from 
Sigma (Steinheim, Germany) unless stated otherwise. Dialysis was performed in regenerated 
cellulose tubes from Spectrum laboratories (Spectra/ Por® 6 Dialysis membrane, molecular 
weight cut-off (MWCO) 1000 g·mol-1, purchased from Roth, Karlsruhe, Germany). The 
deionized water used was purified using a Millipore water purification system with a 
minimum resistivity of 18.0 MΩ·cm. NaH2PO4 and glycine were purchased from Merck 
Chemicals (Darmstadt, Germany), Na2HPO4, Na-dodecylsulfate and bis-ANS were obtained 
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from Sigma-Aldrich (Munich, Germany). NaCl, NaOH and HCl were bought from VWR 
International (Darmstadt, Germany), and D-(+)-mannitol was obtained from Riedel-de-Haen 
(Honeywell Specialty Chemicals Seelze GmbH, Seelze, Germany). 
 Synthesis and Analytics 2.2
Triethoxysilyl modified polymers, LPG(OMe) (1), mPEG (2), and HPG(OH) (3) were 
synthesized as reported earlier [20] (Figure III-1A). HPG(OH) (3a) (GPC: Mn 2.0 kDa, 
Mw 3.1 kDa) and LPG(OMe) (GPC: Mn 2.2 kDa, Mw 2.7 kDa) were synthesized by a one-step 
anionic ring-opening polymerization of glycidol and glycidyl methyl ether, respectively [20-
22]. Triethoxysilyl modified HPG(OMe) (4) was synthesized via a five-step sequence. 
Therefore, 5% of the initially present hydroxy groups of HPG(OH) (3a) were successively 
mesylated with methanesulfonyl chloride (4a) and converted to the corresponding azide (4b) 
with sodium azide analogously to literature [23]. The residual hydroxy groups were 
methylated by means of methyl iodide (4c). Subsequent catalytic hydrogenation of the azide 
groups with Pd/C gave the corresponding amine (4d) which was coupled to 3-
(triethoxysilyl)propyl isocyanate to yield the triethoxysilyl modified HPG(OMe) (4) [20]. 
Amine functionalized HPG(OH) (3b) was synthesized according to literature [23]. 
 
 
Figure III-1: (A) Synthesis and chemical structures of triethoxysilyl modified polymers: 
(a) MsCl, Pyridine, rt, 24 h; (b) NaN3 , DMF, 60 °C, 3 d; (c) KOH, DMSO, MeI, rt, 24 h; 
(d) Pd/C, MeOH, rt, 3 d; (e) 3-(triethoxysilyl)propyl isocyanate, THF, TEA, rt, 20 h; (B) 
Sketch of coated glass vial filled with antibody solution. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of this 
article.) 
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2.2.1 Azide Functionalized HPG(OMe) (4c) 
Azide functionalized HPG(OH) (4b) (2000 g·mol-1, 12.3 g, 6.2 mmol) was dissolved in dry 
DMSO (200 mL) under inert gas atmosphere and KOH (41.7 g, 744 mmol, 120 eq. (4 
eq./OH)) was added. The resulting suspension was vigorously stirred and cooled in a water 
bath. After slow addition of methyl iodide (52.8 g, 23.2 mL, 372 mmol, 60 eq. (2 eq./OH)) the 
mixture was stirred for 24 h under inert gas atmosphere. The reaction was quenched by the 
addition of water, concentrated under reduced pressure, and subsequently dried in high 
vacuum. The resulting residue was treated by water, and the compound was repeatedly 
extracted with DCM. The combined organic layers were dried under reduced pressure to yield 
a yellow honeylike product (12.7 g, 79%). 
1H NMR (400 MHz; CDCl3): δ = 3.64-3.43 (m, 200 H, PG-backbone, secondary –OCH3); 
3.34 (s, 43 H, primary -OCH3); 1.41-1.34 (m, 2 H, CH2CH3 of starter); 0.81 (t, 3 H, CH2CH3 
of starter) ppm. 13C NMR (700 MHz; CDCl3): δ = 79.6-79.2, 78.9-78.5, 72.7-72.6, 72.4-72.2, 
72.0-71.0, 70.6-69.3 (PG-backbone); 59.3-59.2 (primary –OCH3); 58.2-57.9 (secondary -
OCH3); 60.8-60.5 (CHN3); 52.0, 51.6 (CH2N3); 23.7 (CH2CH3 of starter); 7.7 (CH2CH3 of 
starter) ppm. IR νmax/cm
-1: 3361; 2876; 2098; 1460; 1355; 1274; 1196; 1089; 961; 832; 677. 
2.2.2 Amine Functionalized HPG(OMe) (4d) 
Azide functionalized HPG(OMe) (4c) (2500 g·mol-1, 12.7 g, 4.9 mmol) was dissolved in 
MeOH. Pd/C (20 wt%, 2.5 g) was added an the mixture was stirred for 3 d under H2-
atmosphere (5 bar) at rt. The reaction mixture was filtered through Celite® and concentrated in 
vacuo to give a yellow honeylike product (11.3 g, 89%).  
1H NMR (400 MHz; CDCl3): δ = 3.64-3.42 (m, 200 H, PG-backbone, secondary –OCH3); 
3.33 (s, 43 H, primary -OCH3); 1.36-1.32 (m, 2 H, CH2CH3 of starter); 0.81 (t, 3 H, CH2CH3 
of starter) ppm. 13C NMR (700 MHz; CDCl3): δ = 79.5-79.1, 78.8-78.3, 72.6-72.5, 72.3-72.1, 
71.8-70.9, 70.3-69.6 (PG-backbone); 59.2-59.1 (primary –OCH3); 58.0-57.8 (secondary -
OCH3); 50.9-50.7 (CHNH2); 43.2-42.7 (CH2NH2); 23.7 (CH2CH3 of starter); 7.7 (CH2CH3 of 
starter) ppm. IR νmax/cm
-1: 3362; 2875; 1643; 1461; 1356; 1262; 1196; 1085; 960; 832; 679. 
2.2.3 Triethoxysilyl Modified HPG(OMe) (4) 
Triethoxysilyl modified HPG(OMe) (4) was synthesized analogously to literature [20]. 
Therefore amine functionalized HPG(OMe) (4d) (2500 g·mol-1, 4 g, 1.5 mmol) was dissolved 
in dry THF (100 mL) under inert gas atmosphere in a teflon flask. While stirring at rt TEA 
(0.61 g, 0.83 mL, 6 mmol) and 3-(triethoxysilyl)propyl isocyanate (0.59 g, 0.59 mL, 
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2.4 mmol) were added successively and the reaction was allowed to proceed for 20 h. The 
mixture was concentrated under reduced pressure and subsequently dialysed against EtOH to 
yield 4 as yellow honeylike product (3.5 g, 86%). 
1H NMR (700 MHz; CDCl3): δ =  5.17 (brs, 2 H, 2 x NH); 3.73 (q, 6 H, SiOCH2CH3); 3.63-
3.34 (m, 203 H, PG-backbone, secondary –OCH3); 3.29 (s, 43 H, primary -OCH3); 3.08-3.00 
(m, 4 H, 2 x CH2NH); 1.54-147 (m, 2 H, SiCH2CH2CH2NH); 1.32-1.26 (m, 2 H, CH2CH3 of 
starter); 0.76 (t, 3 H, CH2CH3 of starter); 0.54 (t, 2 H, SiCH2CH2CH2NH) ppm. 
13C NMR 
(700 MHz; CDCl3): δ = 158.7 (C=O); 79.5-79.2, 78.8-78.5, 72.6.-72.3, 71.7-71.0, 70.2-69.8 
(PG-backbone, NHCH2CH2CH2O); 59.3-59.1 (primary –OCH3); 58.4-58.2 (OCH2CH3); 58.0-
57.7 (secondary –OCH3); 43.2-42.7 (NHCH2CH2CHO, SiCH2CH2CH2NH); 23.7 (CH2CH3 of 
starter); 23.0 (SiCH2CH2CH2NH); 18.3 (OCH2CH3); 7.7 (CH2CH3 of starter) ppm. IR 
νmax/cm
-1: 3360; 2878; 1644; 1460; 1356; 1261; 1196; 1085; 956; 915; 832; 683. 
1H and 13C NMR spectra were recorded on a Jeol ECX spectrometer operating at 400 MHz 
and a Bruker Avance 3 operating at 700 MHz, respectively at concentrations of 100 mg·mL-1. 
The chemical shifts are reported in δ (ppm) values and were referenced to indicated solvents. 
IR spectra were recorded on a Nicolet Avatar 32 FT-IR with Smart iTR accessory. GPC 
measurements were performed on an Agilent 1100 Series instrument including a refractive 
index detector. PS standards in THF and Pullulane standards in water have been used for 
calibration. The measurements were run in THF and in an aqueous sodium nitrate solution 
(0.1 M), respectively (1 mL min-1, 20 °C), using an array of Suprema Lux 100, Suprema 1000 
and Suprema Lux 3000 columns (dimensions: 8 x 300 mm, particle size: 10 µm, PSS, Mainz, 
Germany). 
 Glass Coating Procedure 2.3
2R Fiolax® glass vials were coated according to a modified procedure described by Weinhart 
et al. [20]. The vials were cleaned and chemically activated by immersion into freshly 
prepared piranha solution (H2SO4:H2O2 = 3:1) for 30 min, followed by thoroughly rinsing 
with Milli-Q water and ethanol. Subsequently, the vials were filled up to the neck with an 
ethanolic solution containing the respective triethoxysilyl modified polymer (0.1·10-3 M·cm-2 
glass surface) and 30% v/v 1 M aqueous acetic acid. The vials were sealed with DuraSeal® 
(Carl Roth, Karlsruhe, Germany) to prevent evaporation and placed in an oven at 40 °C for 
12 h. After cooling down to room temperature the vials were thoroughly rinsed with ethanol 
and dried in a stream of N2. 
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For QCM-D measurements, quartz crystal sensors with a silicon dioxide layer (QSX 303, Q-
Sense AB, Gothenburg, Sweden) were cleaned and chemically activated by immersion into a 
5:1:1 mixture of Milli-Q water, ammonia solution, and H2O2 for 7 min at 70°C, rinsed with 
Milli-Q water and ethanol, and placed in a glass vial containing an ethanolic solution of the 
respective triethoxysilyl modified polymer (0.1·10-3 M·cm-2 glass surface) and 30% v/v 1 M 
aqueous acetic acid, closed with a cap, and placed in an oven at 40 °C for 12 h. Afterwards 
the quartz crystal sensors were thoroughly rinsed with ethanol and dried in a stream of N2. 
 Protein Solutions 2.4
For adsorption experiments, a 2 mg/ml IgG1 solution in 10 mM phosphate buffer adjusted to 
varying ionic strength up to 170 mM with NaCl, was used as standard protein formulation. 
The pH value was adjusted by addition of 1 M NaOH or HCl. Human Growth Hormone 
(hGH) for adsorption experiments was obtained from Genotropin® MiniQuick 0.6 I.E. and 
1.2 I.E. single-use syringes (Pharmacia & Upjohn). After reconstitution of the lyophilisates 
and dilution with corresponding formulation buffer, the solutions contained 0.8 mg/ml hGH, 
formulated in 1.5 mM NaH2PO4, 0.70 mM Na2HPO4, 11.19 mM glycine and 274.25 mM 
mannitol. All protein solutions were filtered through a 0.2 µm polyethersulfone membrane 
filter (Pall GmbH, Dreieich, Germany) before use. Ultrapure water (0.055 lS/cm) for all 
applications was obtained from a Purelab Plus UV/UF system (ELGA LabWater, Celle, 
Germany).  
 Protein Adsorption Testing 2.5
Adsorption experiments were performed in 2R Fiolax® type I borosilicate glass vials uncoated 
or coated with HPG(OH), HPG(OMe), LPG(OMe) or mPEG. Prior to testing, all vials were 
washed with ultrapure water at 80 °C. For standard adsorption testing, the vials were filled 
with 3.5 ml of a 2 mg/ml IgG1 solution or 1 ml of 0.8 mg/ml hGH solution, closed with 
Fluorotec® stoppers, sealed with Flip-Off® seals (West Pharmaceutical Services Deutschland 
GmbH & Co. KG) and incubated at 25 °C for 24 h (Figure III-1B). The inner surface area of a 
vial covered with protein formulation was calculated as 13.4 cm² or 5.06 cm² for a filling 
volume of 3.5 ml or 1 ml, respectively. After incubation, the vials were emptied using a 
syringe. Subsequently, each vial was rinsed four times with the corresponding formulation 
buffer. For desorption of bound protein, 3.5 ml (1 ml for vials with hGH) of 10 mM PBS 
containing 145 mM NaCl and 0.05% SDS (pH 7.2) were filled into each of the vials, which 
were closed and stored overnight at 25 °C [24]. Desorbed protein was quantified via size-
80  Chapter III 
 
exclusion chromatography [24] (Agilent 1100 HPLC, Agilent 1200 fluorescence detector, 
Agilent Technologies GmbH, Boeblingen, Germany), using a TSKgel SWXL guard column 
and a 3000SWXL SEC-column (Tosoh Bioscience GmbH, Stuttgart, Germany). 400 µl per 
sample were injected and eluted with desorption buffer as mobile phase at a flow rate of 
0.75 ml/min. The intrinsic fluorescence signal of the protein was detected at 
λex/λem 280 nm/334 nm. A calibration line was included in each batch. All chromatograms 
were integrated manually using ChemStation Software Rev. B 02.01 (Agilent Technologies 
GmbH, Boeblingen, Germany). 
For long-term adsorption study of IgG1, the vials were heat sterilized at 180 °C for 30 min 
after washing. After filling with 3.5 ml IgG1 solution, the vials were closed with Fluorotec® 
stoppers and sealed with Flip-Off® seals. The incubation time was set to 24 h, one or three 
months at temperatures of 2-8 °C, 25 °C or 40 °C, respectively. After incubation, the IgG1 
solutions were removed from the vials and further used for analysis of the protein stability. 
Adsorbed protein was quantified according to the standard procedure described above. 
For testing of different sterilization methods, the vials were washed and heat sterilized at 
215 °C or 240 °C for 30 min or autoclaved at 121 °C, 2 bar for 15 min prior to filling with 
3.5 ml IgG1 solution. Incubation, desorption and quantification followed the standard 
procedure. 
 Stability Testing of the HPG(OH)-Coating toward pH Change via QCM-D  2.6
The hydrolytic stability of HPG(OH) coatings at various pH was tested using a quartz crystal 
microbalance (QCM-D) (Q-Sense E1, Q-Sense AB, Gothenburg, Sweden) by measuring the 
adsorption of fibrinogen subsequent to treatment of the chip with the respective alkaline or 
acidic aqueous solution. QCM-D allows monitoring the changes in resonance frequency (f) 
and dissipation (D) of a piezoelectric quartz crystal as a function of time. f and D were 
recorded at the fundamental frequency (4.95 MHz) and its 3rd, 5th, 7th, 9th, 11th, and 13th 
overtone. Adsorption layer thickness and adsorbed mass were calculated using the Sauerbrey 
and Voigt model. The Sauerbrey equation is only valid for rigid adsorbed layers and does not 
take into account the dissipation change. Thus, it underestimates the adsorbed mass by up to 
40%. In contrast, the adsorption of a well hydrated protein layer results in a highly 
viscoelastic film which does not fully follow the oscillation of the quartz crystal. Therefore, 
energy is dissipated which causes an increase in D. Since the Sauerbrey model underestimates 
the amount of the deposited mass, the thickness and the mass of the adsorbed protein layer 
was additionally calculated by combining the obtained data of three different overtones 
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(n = 3, 5, 7) based on the Voigt model using the software package Qtools (version 3.0.15.553, 
Q-Sense AB, Gothenburg, Sweden). For intact coatings, where almost no protein adsorption 
occurred, the Voigt model does not fit well the measured data as it overestimates the thickness 
and mass by a factor of 10. Therefore, in these cases only the data calculated by the Sauerbrey 
model is shown. 
Phosphate buffered saline (PBS, 10 x concentrated) (Lonza, Köln, Germany), was diluted to a 
1 x concentration by Milli-Q, passed through a 0.22 µm filter, and degassed prior to use. 
Fibrinogen solutions were prepared at concentrations of 1 mg/ml in PBS (pH 7.4). Alkaline 
and acidic aqueous solutions were prepared by adjusting the pH by adding NaOH (1 M) and 
HCl (1 M) respectively. 
All measurements were performed twice under dynamic conditions at flow rates of 
0.1 ml/min according to the following protocol on HPG(OH) coated and bare quartz crystal 
sensors: injection of (i) Milli-Q water (0.2 mL), (ii) NaOHaq and HClaq of pH 4, 8.5, 10, 11.5 
or 12.5 , respectively (3 ml), (iii) Milli-Q water (2 ml), (iv) PBS (1 ml), (v) fibrinogen (2.5 ml, 
1 mg/ml), (vi) PBS (1 ml). The density of the adsorbed fibrinogen layer was assumed to be 
1200 kg·m-3, the fluid density 1000 kg·m-3, and the fluid viscosity 0.001 kg·ms-1. 
 Protein Stability after Storage 2.7
The stability of the IgG1 formulation (10 mM PBS, 145 mM NaCl, pH 7.2) after 3 months 
storage was investigated in regard to changes in tertiary structure via extrinsic fluorescence 
and for particle formation. Spectra of 0.05 mg/ml IgG1 solutions with 5 µM bis-ANS were 
recorded with a Varian Cary Eclipse fluorescence spectrophotometer (Varian Deutschland 
GmbH, Darmstadt, Germany) at λex 385 nm and λem 420 – 700 nm in 10 x 10 mm 
fluorescence quartz cuvettes at 25 °C. A solution of IgG1 heat stressed at 75 °C for 15 min 
was used as control for unfolded protein. 
Particle formation in the protein solution was investigated by HP-SEC, turbidity 
measurements as well as visible and subvisible particle analysis. Protein aggregates and 
fragments in the protein solutions were quantified via HP-SEC (equipment see 2.5) using a 
YMC-Pack Diol-300 SEC-column (YMC Europe GmbH, Dinslaken, Germany) and a TSKgel 
SWXL guard column (Tosoh Bioscience GmbH, Stuttgart, Germany) with UV-detection at 
λex 280 nm. 100 µl of each sample with a concentration of 2 mg/ml was eluted with 10 mM 
PBS containing 145 mM NaCl, pH 7.2. The content of aggregates, monomer and fragments in 
the sample solutions was calculated in percent of the total protein content of the reference. 
Turbidity of the solutions was measured using a Nephla laboratory turbidimeter (Hach Lange 
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GmbH, Düsseldorf, Germany). Light scattering was detected at an angle of 90 ° in glass 
cuvettes, applying a filling volume of 1.7 ml. Visible particle inspection was performed by 
visual control of the solution in front of a dark background and a light source. Subvisible 
particle analysis was performed via light obscuration with a PAMAS SVSS-35 (PAMAS 
GmbH, Rutesheim, Germany). Three fractions of 0.3 ml of each sample with 0.3 ml pre-run 
volume were analyzed [25]. The system was rinsed with ultrapure water before each 
measurement until no particles larger than 10 µm and less than 100 particles per ml in total 
were measured. Amount and diameter of particles were determined by the PAMAS PMA 
software and are presented in cumulative particles per ml protein solution. 
 Tests of Significance 2.8
The means of two populations were tested for equality by a two-tailed T-test for independent 
samples. Statistical significance is given on the levels p < 0.05, p < 0.01 and p < 0.001. 
Statistics are depicted in the figures only for differences discussed in the text. 
3 RESULTS 
 Effect of Different Polyglycerol Coatings on IgG1 and hGH Adsorption 3.1
To investigate the effect of LPG(OMe), HPG(OH) and HPG(OMe) coatings on protein 
adsorption, the adsorption of IgG1 at different formulation pH and ionic strength conditions 
was quantified and compared to the adsorption to non-coated type I glass vials. The pH values 
of 4 and 7.2 were selected to evaluate the influence of protein charge on IgG1 adsorption. At 
these pH values, the antibody exhibits a very strong or strong positive charge (pI of the 
protein ~8.5). The influence of ionic strength on both intermolecular protein interactions as 
well as protein surface interactions was taken into account by investigating adsorption at low 
(22 mM) and high (170 mM) ionic strength. At pH 4/170 mM, a high IgG1 adsorption of 
4.2 mg/m² to type I glass vials was found, compared to less than 2 mg/m² at pH 7.2 (Figure 
III-2). At pH 4/22 mM, adsorption was lower than at 170 mM ionic strength. This 
corresponds to the pH and ionic strength dependent protein adsorption behavior described in 
the literature [24]. At all three conditions, IgG1 adsorption was significantly suppressed 
(p < 0.01) by all tested polyglycerol coatings (Figure III-2). The pH and ionic strength effect 
on the protein adsorption as seen for non-coated glass vials were of marginal relevance for the 
PG-coated vials. Adsorption to HPG(OH)-coated vials tended to be lower than to 
methoxylated HPG-coated vials, but the effect was not always significant. 
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We also tested the adsorption of the therapeutic protein human Growth Hormone (hGH) to 
HPG(OH)-coated vials (Figure III-3) because this coating was superior compared to other 
PG-coatings at some conditions. The tests were based on the composition of the commercially 
available formulation of Genotropin® MiniQuick 0.6 I.E. aiming for highly relevant 
conditions. Again, the amount of hGH adsorbed was significantly lower on the HPG(OH)-
coated vials compared to non-coated glass vials (Figure III-3). At 25 °C, hGH adsorption of 
2.62 mg/m² to type I glass vials was reduced to 0.72 mg/m² by the HPG(OH)-coating. The 
higher adsorption to glass vials observed after storage at 25 °C compared to 2-8 °C was not 
observed with the HPG(OH)-coated vials. 
 
Figure III-2: IgG1 adsorption to type I borosilicate glass vials, HPG(OH)-, HPG(OMe)-
and LPG(OMe)-coated glass vials at different pH values and ionic strength (*p < 0.05, 
**p < 0.01, ***p < 0.001). n=3. 
 
Figure III-3: Adsorption of hGH to type I glass vials and HPG(OH)-coated vials after 
24 h incubation time at 2-8 °C and 25 °C (*p < 0.05, **p < 0.01), n=3. 
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 Influence of Sterilisation on Polyglycerol Coatings 3.2
For parenteral pharmaceutical products and for various other applications, sterilized vials are 
mandatory. Consequently, the protein repellent properties of the HPG(OH)-, HPG(OMe)-, 
and LPG(OMe)-coatings were tested after 30 min heat sterilization at 215 °C and 240 °C. 
Additionally, the effect of autoclaving (121 °C, 2 bar, 15 min) on the coating stability was 
investigated. mPEG served as reference. 
Sterilization with dry heat for 30 min at 215 °C resulted in only slight changes of IgG1 
adsorption for the HPG-coated vials. In contrast, adsorption to LPG(OMe) and mPEG-coated 
vials clearly increased (Figure III-4), indicating thermal damage, presumably decomposition 
of the coating. Sterilization at 240 °C led to increased adsorption to all coatings, due to the 
expected thermal instability of all PG-coatings. The results indicated higher resistance of 
HPG(OH)- and HPG(OMe)-coating at temperatures above 195 °C compared to mPEG and 
LPG(OMe). Again, protein adsorption was most efficiently suppressed on HPG(OH)-coated 
vials. Autoclaving of the vials did not cause an essential increase in IgG1 adsorption to 
HPG(OH)-, HPG(OMe)- and LPG(OMe)-coated vials compared to the non-sterilized vials 
(Figure III-4). Adsorption values for autoclaved mPEG-coated vials were below the range of 
the calibration line (data not shown). 
 Long-Term Effect of Polyglycerol Coating on Protein Adsorption 3.3
To test the stability of the protein repellent effects of the PG coating, IgG1 adsorption to 
HPG(OH)-coated vials up to 3 months was investigated. Again, we opted for the HPG(OH) 
 
Figure III-4: Adsorption of IgG1 to type I borosilicate glass vials, HPG(OH)-, 
HPG(OMe)-, LPG(OMe)- and mPEG-coated glass vials after heat sterilization and 
autoclaving (*p < 0.05, **p < 0.01, ***p < 0.001), n ≥ 2. 
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coated vials as they showed the best protein repellent effects and stability in the previous 
tests. IgG1 adsorption to type I borosilicate glass vials did not change significantly for 
1 month (Figure III-5). After 3 months, the amount adsorbed at 2-8 °C and 40 °C was slightly 
higher than at 25 °C, but without statistical significance. IgG1 adsorption to HPG(OH)-coated 
vials was significantly lower than on type I glass vials at all temperatures and time points. 
IgG1 adsorption remained constant for 1 month. After 3 months, adsorption at 40 °C was 
significantly increased. A tendency to higher protein adsorption levels at 2-8 °C after 
3 months might be speculated but the difference to the 24 h and 1 month data was not 
significant (p < 0.05). 
 Effect of HPG(OH)-Coating on IgG1 Stability in Solution  3.4
To ensure protein stability upon prolonged exposure to HPG(OH)-coated vials, we analyzed 
protein solutions after 3 months storage for visual appearance, subvisible particles, the 
occurrence of aggregates and fragments as well as changes in protein structure by extrinsic 
fluorescence spectroscopy. All solutions were visually unchanged. Turbidity measurements 
revealed only marginal changes compared to a fresh IgG1 solution. The counts of particles 
≥ 10 µm and ≥ 25 µm were found to be slightly increased compared to the IgG1 starting 
solution, but were still significantly below the pharmacopoeial acceptance level of less than 
6000 particles ≥ 10 µm and 600 particles ≥ 25 µm per container [26] which equals 3.5 ml for 
the applied 2R vials and did not differ significantly between the vial species at the same 
storage temperatures (Figure III-6). The monomer content analyzed by HP-SEC remained 
 
Figure III-5: Adsorption of IgG1 to type I glass vials (A) and HPG(OH)-coated vials (B) 
after storage for up to 3 months at different temperatures (*p < 0.05, **p < 0.01, 
***p < 0.001), n=3, samples marked with ×: n=2. 
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constant at about 94-96% (Figure III-7) and only samples stored at 40 °C showed a slightly 
enhanced fragmentation for both vial species. 
The tertiary structure of IgG1 was analyzed by extrinsic fluorescence spectroscopy using bis-
ANS as dye. The almost non-fluorescent dye exhibits a strong fluorescence in contact with a 
nonpolar environment such as hydrophobic domains in proteins [27]. Samples stored in type I 
glass vials and HPG(OH)-coated vials showed an equally pronounced, slight shift of the 
  
Figure III-6: Turbidity and number of particles determined in IgG1 solutions stored in 
type I glass vials (A) and HPG(OH)-coated vials (B) for 3 months at different 
temperatures, n=3. 
  
Figure III-7: Content of monomer, aggregates and fragments in IgG1 solutions stored in 
type I glass vials (A) and HPG(OH)-coated vials (B) for 3 months at different 
temperatures. Values given in percent of the total protein content of the reference. n=3, 
samples marked with ×: n=2. 
t=0 2-8 °C 25 °C 40 °C 2-8 °C 25 °C 40 °C
0
50
100
800
1200
1600
2000
Storage temperature 
B
P
ar
ti
cl
es
 p
er
 m
l
 ≥ 1 µm
 ≥ 10 µm
 ≥ 25 µm
A
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
 T
ur
bi
di
ty
 (
F
N
U
)
t=0 2-8 °C 25 °C 40 °C 2-8 °C 25 °C 40 °C
0
2
4
6
8
90
100
110
×
×
×
×
×
×
 Storage temperature 
BA
C
on
te
nt
 (
%
)
 aggregate
 monomer
 fragment
 
Polyglycerol Coatings of Glass Vials for Protein Resistance 87 
 
fluorescence maximum and slightly increased fluorescence intensity compared to the native 
antibody (Figure III-8). Storage at different temperatures did not change the extrinsic 
fluorescence. A heat stressed reference was included as a control to illustrate increased bis- 
ANS fluorescence due to protein unfolding with a distinct blue shift of the maximum from 
about 525 nm to about 494 nm. 
 Stability Testing of the HPG(OH)-Coating toward pH Change via QCM-D 3.5
The stability of HPG(OH) modified glass surfaces toward hydrolysis was tested by measuring 
the protein repellent effect of coated quartz crystals after treatment with aqueous solutions in 
the pH range from 4 to 12.5 by QCM-D. Hydrolytic cleavage of the siloxane bonds which 
link the polymer to the glass surface causes a loss of the tethered polymer, resulting in an 
increased protein adsorption. Values from QCM-D measurements as well as calculated values 
using the Sauerbrey and Voigt model are summarized in Table III-1. Typical plots of ∆f and 
∆D are shown in Figure III-9 a and b. Fibrinogen served as model protein for these 
experiments due to its high adsorption tendency to various surfaces [28, 29]. Thus, a high 
sensitivity of the measurements toward changes in the surface properties was ensured. 
Furthermore, fibrinogen had been previously used to investigate adsorption to PG-coated 
surfaces [20, 30] allowing good comparability of the results.  
The total mass measured by QCM-D includes both the mass of the adsorbed fibrinogen and of 
the associated water, i.e., water trapped in cavities, the hydration layer, and hydrodynamically 
 
Figure III-8: Fluorescence spectra of IgG1 solutions after 3 months storage in type I 
glass vials (A) and HPG(OH)-coated vials (B) in presence of 5 µM bis-ANS; storage 
temperature 2-8 °C (----), 25 °C (·····), 40 °C (──). Samples n=3, heat stressed and native 
reference n=1. 
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coupled water [31]. Since the associated water content of an adsorbed fibrinogen layer can 
account for up to 70% of the detected mass, the values given in Table III-1 are considerably 
higher than adsorbed masses determined with optical techniques [29]. Taking into account 
this high water percentage of the adsorbed layer the results obtained by QCM-D are in good 
agreement with our previous protein adsorption studies on glass slides using fluorescence 
microscopy [20]. 
At pH 7.4, no protein adsorption occurred. After treatment with aqueous solution at pH 4 and 
8.5 the amount of adsorbed fibrinogen was almost identical to the amount adsorbed onto 
untreated HPG(OH) modified glass surfaces (Figure III-9a and b). These results suggest that 
HPG(OH) modified glass surfaces are not susceptible toward hydrolysis under typically used 
protein formulation conditions. In contrast, at pH 10, the siloxane bond is more susceptible to 
hydrolysis, which becomes evident from the increased fibrinogen adsorption. By gradually 
increasing the pH leading to a loss of the HPG(OH) functionalization, the amount of adsorbed 
fibrinogen further increased. At pH 12.5 it reached the same level as fibrinogen adsorption to 
bare SiO2 (Figure III-9a and b). 
Table III-1: QCM-D results for testing hydrolytic stability of HPG(OH)-silyl (3) coatings 
on quartz crystal sensors after injection of 2.5 mL fibrinogen (1 mg·ml
-1
). Normalized 
data for the 3rd overtone are shown (∆f3/3). Thickness and mass of the adsorbed 
fibrinogen layer were calculated according to the Voigt and the Sauerbrey model, 
respectively. 
pH ∆f3/3 [Hz] 
∆D3 
[10-6] 
Average thickness of 
adsorbed fibrinogen layer 
[nm] 
Mass of adsorbed fibrinogen 
layera [mg/m2] 
Sauerbrey Voigt Sauerbrey Voigt 
4.0 -1.38±0.08 0.81±0.02 0.21±0.01 - 0.24±0.01 - 
8.5 -1.34±0.12 0.69±0.05 0.20±0.01 - 0.24±0.02 - 
10 -25.76±0.73 5.36±1.50 3.84±0.11 5.98±0.30 4.61±0.13 7.24±0.27 
11.5 -68.31±0.90 14.74±0.41 10.01±17 15.50±0.79 12.23±0.18 18.60±0.93 
12.5 -117.30±1.40 16.32±0.28 17.49±0.21 24.38±1.22 20.99±0.25 27.80±1.46 
7.4 -1.56±0.17 0.89±0.11 0.23±0.03 - 0.27±0.03 - 
bare SiO2 -108.30±2.08 11.29±1.37 16.15±0.31 27.15±6.96 21.67±1.93 32.57±8.35 
aThe total mass of the adsorbed fibrinogen layer includes the mass of the associated water, i.e. 
water trapped in cavities, the hydration layer, and hydrodynamically coupled water [29, 31]. 
Polyglycerol Coatings of Glass Vials for Protein Resistance 89 
 
4 DISCUSSION 
Linear and hyperbranched (methoxylated) polyglycerols were synthesized and characterized 
previously [20] showing excellent protein repellent effects. However, to date only gold and 
flat glass slides have been coated with these polymers and to our best knowledge no studies 
 (a) 
  
 (b) 
  
Figure III-9: QCM-D frequency changes ∆f3/3 (a) and dissipation changes ∆D3 (b) of 
fibrinogen adsorption to HPG(OH)-silyl (3) coated and unmodified glass surfaces after 
30 min. treatment with alkaline or acidic aqueous solutions. 
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on relevant packaging material such as glass vials have been conducted. Therefore, we tested 
the protein adsorption to industrial relevant type I borosilicate glass vials coated with linear 
methoxylated (LPG(OMe)), hyperbranched (HPG(OH)) and hyperbranched methoxylated 
(HPG(OMe)) polyglycerol, and the coating stability to elucidate its feasibility for the 
application in the pharmaceutical industry. 
Exemplary QCM-D measurements performed on HPG(OH)-coated quartz crystals revealed a 
very good coating stability (Table III-1, Figure III-9). At pH values above 10, fibrinogen 
adsorption increased significantly due to hydrolytic cleavage of the siloxane bond and a loss 
of the coating. Nevertheless, these alkaline pH values are not relevant for typical 
pharmaceutical protein formulations. Therefore, further protein adsorption experiments were 
performed at formulation relevant pH values between 4 and 7.2. 
Protein adsorption was reduced significantly using the PG-coated vials compared to 
conventional glass vials. Furthermore, these coatings reduced the impact of the pH and of the 
ionic strength on the protein adsorption (Figure III-2). In contrast, using bare glass (vials) the 
unspecific protein adsorption strongly depends on these parameters (Figure III-2). Mathes et 
al. investigated the adsorption of IgG1 to borosilicate glass vials and found similar adsorption 
trends in regard to pH and ionic strength [24]. The author ascribed these trends to the 
interplay of attractive electrostatic protein-sorbent interactions and intermolecular repulsion 
on the surface which are both influenced by the ionic strength. Borosilicate glass was found to 
be negatively charged at pH values above pH 2.3 [24], whereas our antibody exhibited a very 
strong or strong positive charge at pH 4 and 7.2 respectively (pI~8.5). This stronger positive 
charge of the antibody at pH 4 thus supposedly led to increased electrostatic attraction and 
higher adsorbed amounts compared to pH 7.2. On the other hand, electrostatic repulsion 
between the molecules at pH 4 was increased due to the high positive charge of the protein. 
Decreasing the ionic strength at pH 4 from 170 mM to 22 mM resulted in a decreased 
shielding of this repulsion by ions in solution and thus to reduced adsorbed amounts, a trend 
which was described previously [24]. On PG-coated vials, the coating screened the charge of 
the surface and thus electrostatic attraction between the protein and sorbent. Similarly, Pasche 
et al. suggested that PEG layers of sufficient thickness facilitate the shielding of charges in the 
interface and thus contribute to adsorption prevention [32]. Hence, the marginal influence of 
pH and ionic strength on IgG1 adsorption to PG-coated vials may be related to the effective 
suppression of electrostatic interactions between the surface and the protein. 
Besides protein repellent effects also good thermal stability of the coating material is 
important as basic industrial sterilization processes such as heat sterilization are normally 
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performed at temperatures ≥ 200 °C. Effective suppression of the protein adsorption can only 
be expected when the protein repelling coating is still intact and stable after the sterilization. 
Those preconditions cannot be met by PEG as its decomposition onset is at 195 °C. In 
contrast, polyglycerol is thermally stable up to 226 °C [13]. Our data clearly showed 
consistent protein resistance of the HPG-coatings after sterilization at 215 °C but increased 
adsorption to LPG(OMe)- and mPEG-coated vials compared to the non-sterilized vials 
(Figure III-4). The reduced repellent effects after sterilization at 240 °C may be ascribed to 
the onset of thermal decomposition that was observed above 226 °C for PG [13] although the 
protein resistance was still superior to the uncoated glass vials. Nevertheless, more detailed 
studies on the thermal stability of our coatings are needed. 
In previous studies, LPG(OMe) exhibited a better protein resistance than HPG(OH) [20]. In 
comparison, our adsorption studies showed a superiority of HPG(OH) at low ionic strength 
(Figure III-2). This trend was confirmed after sterilization of the vials at 215 °C (Figure III-4). 
In contrast to our experiments, Weinhart et al. studied the protein adsorption on flat glass 
slides at one ionic strength and without considering industrially mandatory sterilization 
processes and storage stability [20]. Hence, the deviation of the obtained results supposedly 
resulted from the different protein formulations but also from the processing of the coated 
vials before adsorption. This underlines the importance of industrial relevant conditions 
during the testing of new coating materials. For all adsorption experiments with IgG1, 
saturation conditions and thus an unchanged adsorption mechanism should be provided. 
Adsorption isotherms of IgG showed adsorption plateau values at equilibrium concentrations 
of about 1 to 2 mg/ml [7, 33]. Therefore, we chose a concentration of 2 mg/ml IgG1 for the 
adsorption experiments. In comparison, hGH adsorption plateaus were possibly not reached at 
a concentration of 0.8 mg/ml in the original formulation.  
Stability of the coating material in vials filled with formulation is another prerequisite for a 
primary packaging material of sensitive drugs. QCM measurements and adsorption 
experiments showed excellent protein repellent effects for the range pH 4-8.5. Nevertheless, 
the incubation times during these experiments were only 30 min and 24 h. Partial hydrolysis 
of the coating can occur over weeks and months which is even more relevant for 
pharmaceutical packaging material. Therefore, IgG1 adsorption onto HPG(OH)-coated vials 
was investigated for a longer period. Even after 3 month storage of IgG1 we did not see 
significant changes in the protein repellent effects of our coating material HPG(OH) for 
storage at 2-8 °C and 25 °C, a trend to a slight increase could be speculated (Figure III-5). In 
terms of protein stability, the focus lay on protein aggregates as they may cause severe 
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immunological reactions or affect the efficacy of the drug [34]. In our study, we did not detect 
considerable differences in soluble aggregates, subvisible and visible particles and extrinsic 
fluorescence between formulations stored in coated and non-coated vials (Figure III-6, Figure 
III-7 and Figure III-8), indicating that the HPG(OH)-coating material did not impair protein 
stability. 
5 CONCLUSION 
In conclusion, we describe the successful coating of type I borosilicate glass vials, which are 
the main primary packaging material for many biomacromolecular drugs including proteins, 
with polyglycerols. Especially the hyperbranched, hydroxy-terminated polyglycerol coatings 
exhibit excellent protein resistant effects also after sterilization and long-time storage. 
Therefore, it is a highly promising candidate for the improvement of biomedical packaging 
materials. 
Due to the high protein concentrations used in this study, the relative protein loss was rather 
low. Nevertheless, the evaluation of protein repellent materials is of high importance as the 
protein loss can be substantial in low concentrated protein formulations. Finally, the potential 
for the formation of aggregates and thus an increased risk of immune responses [4] due to 
adsorption is presumably independent of the relative protein loss from solution. 
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Abstract 
The unspecific adsorption of therapeutic proteins to process materials or the primary 
packaging may lead to major concerns such as reduced drug concentration, protein 
aggregation or denaturation. Therefore, it is crucial to understand the mechanisms underlying 
the adsorption process. This study focuses on the adsorption of the F(ab’)2 and the Fc 
fragment of a monoclonal IgG1 antibody to borosilicate glass vials and siliconized glass vials 
as relevant containers for liquid pharmaceutical formulations. The adsorption behavior of the 
fragments and IgG1 was investigated at different pH and ionic strength conditions to evaluate 
the contribution of electrostatic interactions to the adsorption process. On borosilicate glass 
vials, the adsorption of IgG1 and the fragments was found to be strongly dependent on pH and 
ionic strength, a trend that was especially pronounced for F(ab’)2. The largely higher adsorbed 
amounts and the lower ionic strength dependence at basic pH values on siliconized vials 
showed the importance of hydrophobic interactions for adsorption of IgG1 and the fragments 
on this hydrophobic surface. In a competitive adsorption of Fc and F(ab’)2, the total adsorbed 
amount protein on borosilicate glass vials was lower than the corresponding IgG1 adsorption. 
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On siliconized vials, Fc / F(ab’)2 adsorption was found comparably high at some formulation 
conditions. The found adsorbed amounts of IgG1 and the fragments were correlated with 
calculated adsorption values for different molecular surface orientations. It was postulated, 
that IgG1, F(ab’)2 and Fc in a weakly charged state attach preferentially with the hinge region 
of the antibody to the hydrophobic siliconized glass surface. For highly charged IgG1, 
adsorption in an end-on conformation was suggested due to the high surface coverage found 
on borosilicate glass vials and siliconized glass vials. 
1 INTRODUCTION 
The adsorption of proteins to a variety of surfaces is a common phenomenon in nature which 
plays an important role in many biological processes. For pharmaceutical protein 
formulations, major problems may arise from the nonspecific binding of proteins to e.g. filters 
and tubings during processing, but also from the adsorption to the primary packaging 
material. Besides syringes that comprise about 25-30% of the containers for small volume 
injectables, more than 50% of these formulations are packed in vials [1]. As the transfer of 
plastic vials in an aseptic environment is a challenging task [1], the majority of the 
formulations is stored in glass vials or also siliconized vials. A thorough understanding of the 
mechanism of protein adsorption to these packaging materials is crucial to prevent adverse 
effects, which may lead to instabilities of the formulation. In the last decades, the influence of 
different formulation parameters such as pH, ionic strength and surfactants on protein 
adsorption was investigated in detail [2-5]. In particular, there has been a constant growth in 
research on the adsorption of antibodies to various surfaces [6-8], as monoclonal antibodies 
comprise a growing group of biopharmaceuticals on the market [9]. 
It is well known that protein adsorption to surfaces is governed e.g. by electrostatic or 
hydrophobic interactions [6, 10, 11]. However, there are many different opinions about the 
orientation of antibodies on hydrophilic and hydrophobic surfaces. Three main conformations 
have been postulated, which include the preferential binding of the antibody via the Fc 
fragment, the F(ab’)2 fragment or involving the hinge region of the antibody. One argument 
for Fc-mediated adsorption was the binding of anti-F(ab’)2 to adsorbed IgG [12]. Buijs et al. 
investigated the adsorption of IgG, F(ab’)2 and Fc and concluded that IgG adsorbed 
preferentially with the Fc fragment since the Gibbs energy barrier for adsorption was much 
higher for F(ab’)2 than for IgG in some cases [13]. He further suggested adsorption of IgG1 
by its Fc part at some conditions due to the low structural stability of this fragment [14]. In 
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contrast, Vermeer suggested a binding of IgG to hydrophobic Teflon by its more hydrophobic 
Fab’ fragment [15]. Finally, in some recent studies it was suggested, that IgG adsorbs neither 
with Fab’ nor Fc to hydrophobic surfaces, but attaches primarily with the hinge region and 
parts of the Fc fragment [7, 16]. 
In most of these investigations, model surfaces or hydrophobic membranes were used to study 
the adsorption of IgG and its fragments. The present study examines the adsorption behavior 
of IgG1, the F(ab’)2 and the Fc fragment to borosilicate glass vials and siliconized glass vials 
as relevant pharmaceutical packaging materials. The adsorption of the proteins was 
investigated at different pH values and ionic strengths to evaluate the influence of electrostatic 
and hydrophobic interactions on the adsorption process. Moreover, the total adsorbed amount 
of protein in a competitive adsorption of the Fc and F(ab’)2 fragment was investigated. 
Finally, the calculated theoretical surface concentration for different orientations of the 
molecules on the surface was correlated with the found adsorbed amounts of IgG1. This 
allowed us to evaluate the possible orientations of IgG1 on siliconized glass vials and 
borosilicate glass vials at different pH and ionic strength. 
2 MATERIALS AND METHODS 
 Chemicals 2.1
Trometamol was obtained from Merck KGaA (Darmstadt, Germany) and NaH2PO4 was from 
Merck Chemicals (Darmstadt, Germany). Na2HPO4, sodium dodecyl sulfate (SDS), cysteine, 
ethylene diamine tetraacetate (EDTA), iodoacetamide as well as the papain suspension from 
papaya latex and pepsin from porcine gastric mucosa were purchased from Sigma-Aldrich 
Chemie GmbH (Munich, Germany). NaCl, NaOH and HCl were purchased from VWR 
International (Darmstadt, Germany). 
 IgG1 Antibody 2.2
The 2 mg/ml IgG1 antibody formulated in 10 mM phosphate buffer and 145 mM NaCl 
(pH 7.2) was kindly donated by Merck Serono (Darmstadt, Germany). For an adjustment of 
the ionic strength, the formulation was dialyzed in 10 mM phosphate buffer pH 7.2, using a 
Vivaflow® 50 tangential flow cartridge (Sartorius-Stedim Biotech, Goettingen, Germany) 
with a 30 kD MWCO polyethersulfone membrane. The concentration of the protein solution 
was determined by UV-spectroscopy. For adsorption experiments at different pH values, the 
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pH was adjusted by addition of 1 M NaOH or HCl and a consistent ionic strength of 170 mM 
was adjusted by adding adequate amounts of NaCl to the dialyzed solution. 
 Fc Fragments 2.3
Fc fragments were generated by digestion of the antibody with papain. Prior to digestion, the 
IgG1 antibody was dialyzed into a digestion buffer containing 100 mM trometamol, 10 mM 
cysteine and 40 mM EDTA, pH 7.4, using Vivaflow® cartridges with a 30 kDa MWCO 
polyethersulfone membrane (Sartorius AG, Goettingen, Germany). The IgG1 concentration 
was measured by UV-spectroscopy and adjusted to 2 mg/ml. Just before use, the papain 
suspension was diluted with 5 mM cysteine buffer to a final concentration of 1 mg/ml, and 
10 µg papain per mg IgG1 were added to the antibody solution. The mixture was incubated 
for 5-7 h at 37 °C until at least 95% of the protein molecules were digested. Then the reaction 
was stopped by addition of iodoacetamide to a final concentration of 30 mM. In-process 
controls were performed by HP-SEC. Fc fragments were separated from the digestion mixture 
on an ÄKTApurifier 10 (GE Healthcare Europe GmbH, Freiburg, Germany) with a Pierce® 
Protein A Chromatography Cartridge (Thermo Fisher Scientific Inc., IL, USA). The column 
was equilibrated with binding buffer consisting of 100 mM phosphate and 3 M NaCl, pH 9, at 
a flow rate of 1 ml/min. After injection of the digestion mixture, Fab’ fragments were 
immediately eluted from the column. Fc fragments and non-digested IgG1 antibody were 
eluted from the column by applying a gradient toward 100% elution buffer containing 
100 mM phosphate, pH 3, and were collected by an automated fraction collector (Frac-920, 
GE Healthcare Europe GmbH, Freiburg, Germany). UV-absorption at 280 nm was used to 
detect eluted protein. Subsequently, the Fc fragments were dialyzed extensively against 
10 mM phosphate buffer pH 7.2 using Vivaspin® centrifuge tubes with a 10 kDa MWCO 
polyethersulfone membrane (Sartorius AG, Goettingen, Germany). A purity of about 95% Fc 
with small quantities of residual larger fragments was found in non-denaturing HP-SEC and 
was visualized by SDS-PAGE (Figure IV-1a). The isoelectric point of the Fc fragment was 
determined by IEF in a pH range of 6.5-7.6 (Figure IV-1b). pH and ionic strength adjustments 
were performed as described for the IgG1 antibody solution. 
 F(ab’)2 Fragments 2.4
For the preparation of F(ab’)2 fragments, the IgG1 antibody was dialyzed into a digestion 
buffer containing 100 mM Na-acetate, pH 3.5, using Vivaflow® cartridges with a 30 kDa 
MWCO polyethersulfone membrane (Sartorius AG, Goettingen, Germany). The protein 
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concentration was measured by UV-spectroscopy and adjusted to 2 mg/ml. 10 µg pepsin 
dissolved in digestion buffer were added per mg IgG1. For digestion, the reaction solution 
was incubated at 37 °C for 1 h and subsequently stopped by addition of 3 M tris buffer to a 
final pH of 8.8. For adsorption experiments, the solution was dialyzed extensively against 
10 mM phosphate buffer pH 7.2 to remove smaller fragments and pepsin from the solution. 
The purity of the F(ab’)2 fraction was found to be about 96% in non-denaturing HP-SEC with 
some smaller fragments remaining from digestion which was also shown by SDS-PAGE 
(Figure IV-1a). The isoelectric point was determined to be in a pH range of 7.6-8.3 (Figure 
IV-1b). Both pH and ionic strength adjustments were performed as described for the IgG1 
antibody solution. 
 Vials and Closure Systems 2.5
Adsorption experiments were performed in pre-siliconized (Dow Corning 365) and baked 2R 
glass vials and bare Fiolax® glass vials which were kindly provided by SCHOTT AG (Mainz, 
Germany). All vials were washed with ultrapure water of 80 °C in a vial washing machine 
FAW 500 (Bausch&Stroebel GmbH & Co. KG, Ilshofen, Germany). Subsequently, 
siliconized vials were autoclaved at 121 °C, 2 bar for 15 minutes whereas Fiolax® glass vials 
were heat sterilized at 250 °C for 1 h. After filling, the vials were closed with Fluorotec® 
stoppers and sealed with Flip-Off® seals (West Pharmaceutical Services, Eschweiler, 
Germany). The inner surface area of a vial covered with protein formulation was calculated as 
5.06 cm² for a filling volume of 1 ml. 
 Adsorption Process 2.6
The adsorption process followed the procedure described by Mathes & Friess [6]. For 
adsorption testing of the individual fragments or IgG1, 1 ml protein solution containing IgG1, 
F(ab’)2 or Fc fragment in equal molar concentration, corresponding to 1 mg/ml IgG1, 
0.66 mg/ml F(ab’)2 fragment or 0.33 mg/ml Fc fragment, was filled into the pre-processed 
vials (n=2). The simultaneous adsorption of F(ab’)2 and Fc fragment was investigated with 
solutions containing 0.66 mg/ml F(ab’)2 fragment and 0.33 mg/ml Fc fragment (n=2). After 
filling, the vials were closed, sealed and incubated at 25 °C for 24 h. The vials were emptied 
using a syringe with an injection needle. Each vial was rinsed four times with corresponding 
formulation buffer. For desorption of bound protein, 1 ml of 10 mM PBS containing 145 mM 
NaCl and 0.05% sodium dodecyl sulfate, pH 7.2, was filled into each vial. The vials were 
closed and stored overnight at 25 °C. 
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 UV-Spectroscopy 2.7
UV-spectroscopy to determine the concentration of the protein solutions was performed on an 
Agilent 8453 UV/VIS spectrophotometer (Agilent Technologies GmbH, Boeblingen, 
Germany) in 10 x 10 mm quartz cuvettes at λ = 280 nm / 25 °C. For IgG1 an extinction 
coefficient of 1.4 cm²/mg for antibodies was applied. For concentration determination of the 
F(ab’)2 or Fc fragment, the experimentally determined extinction coefficients of 1.45 cm²/mg 
or 1.51 cm²/mg, respectively, were applied. 
 HP-SEC 2.8
In-process controls of IgG1 digestion with papain or pepsin as well as purity analysis of the 
fragments were performed by HP-SEC on an Agilent 1100 HPLC device with an Agilent UV-
detector (Agilent Technologies GmbH, Boeblingen, Germany) using a YMC-Pack Diol-300 
SEC-column (YMC Europe GmbH, Dinslaken, Germany) for sample separation. 10 mM 
phosphate buffer containing 145 mM NaCl, pH 7.2, was used as eluent. A flow rate 
0.5 ml/min was applied with UV-detection at 280 nm. Agilent ChemStation Software 
Rev. B 02.01 was used for manual integration of the chromatograms. The purity of the Fc and 
F(ab’)2 fractions was determined by calculating the percentage of the AUC of each fragment 
from the total AUC of the digestion mixture (n ≥ 1). 
Quantitative analysis of the desorbed protein was performed using a YMC-Pack Diol-300 
SEC-column (YMC Europe GmbH, Dinslaken, Germany) for sample separation. Intrinsic 
protein fluorescence was detected at λex/λem 280 nm/334 nm. Desorption buffer was used as 
mobile phase. For the quantification of IgG1 or the separated fragments, a calibration line of 
each of the proteins was included in an HPLC batch. For protein quantification in samples 
containing Fc and F(ab’)2, a calibration line with different ratios of Fc and F(ab’)2 as well as 
pure Fc and pure F(ab’)2 was included in each HPLC batch. The chromatograms were 
integrated manually using the Agilent ChemStation Software Rev. B 02.01. 
 Determination of the Molar Extinction Coefficient of Fc and F(ab’)2 2.9
Fragments 
The molar extinction coefficient ε of Fc and F(ab’)2 fragments was calculated from 
experimentally obtained values according to the following equation: 
ε 	
∙
   (1) 
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c constitutes the molar concentration of the analyte obtained by micro BCA-assay, A280 is the 
corresponding UV-absorption of the solution at 280 nm (n=3) and d equals the pathlength of 
the cuvette. The experimentally obtained values were confirmed by calculation of the 
theoretical molar extinction coefficients from the protein sequence applying equation (2). This 
equation is based on experimentally determined intrinsic extinction coefficients of tryptophan, 
tyrosine and cystine residues and their number n in the protein sequence [17, 18]: 
ε 5540n 1480n 134n   (2) 
The sequence of the fragments was obtained from the amino acid sequence of the full 
antibody under consideration of the cleavage sites of papain between histidine-threonine in 
the upper hinge region for the Fc fragment [19, 20] or pepsin between leucine-leucine for the 
F(ab’)2 fragment in the lower hinge region [20], respectively. The theoretical extinction 
coefficients were calculated as 1.45, 1.44 and 1.46 cm²/mg for IgG1, Fc and F(ab’)2 and an 
assumed molecular weight of 150, 50 and 100 kDa, respectively. 
 Micro BCA-Assay 2.10
The protein concentration of Fc and F(ab’)2 in 10 mM phosphate buffer pH 7.2 was 
determined with a micro BCA protein assay kit (Thermo Fisher Scientific Inc., IL, USA). 
From each fragment solution, two dilutions were prepared in triplet each and analyzed in a 
96-well plate with UV-detection at 562 nm. A 6-point calibration line of non-fragmented 
IgG1 in a concentration range of 2.5-40 µg/ml was used as reference for quantification. 
 SDS-PAGE 2.11
The digestion products were analyzed by SDS-PAGE using NuPAGE® 7% tris-acetate gels 
(Life Technologies GmbH, Darmstadt, Germany). Samples were diluted with formulation 
buffer to 0.0125 mg/ml and heat denatured at 95 °C for 20 min. A Mark12™ Unstained 
Standard (Life Technologies GmbH, Darmstadt, Germany) was applied for band 
identification. Electrophoresis was performed at a consistent current of 0.04 A for approx. 
1.5 h, followed by silver staining with a SilverQuest™ Silver Staining Kit (Life Technologies 
GmbH, Darmstadt, Germany). 
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 Isoelectric Focusing 2.12
The isoelectric point of IgG1, Fc and F(ab’)2 fragments was determined by isoelectric 
focusing (IEF) using precast SERVALYT PRECOTES® 6-9 IEF plates with a thickness of 
300 µm. 10 µl per sample with a concentration of 0.5 mg/ml adjusted by dilution with 
ultrapure water and SERVA Liquid Mix IEF marker 3-10 (SERVA Electrophoresis GmbH, 
Heidelberg, Germany) were applied to the gel. Electrophoresis was performed at 2000 V and 
6 mA at 5 °C. The gels were stained with SERVA Blue W (SERVA Electrophoresis GmbH, 
Heidelberg, Germany). 
3 RESULTS AND DISCUSSION 
 Adsorption of IgG1, F(ab’)2 and Fc Fragment 3.1
The adsorption behavior of IgG1 and the individual Fc and F(ab’)2 fragments to borosilicate 
glass vials and siliconized glass vials was investigated using solutions of equimolar 
concentration. Adsorption was tested at the pH values 4.0, 7.2 and 8.6, so that the impact of 
different charge states of the molecules on the adsorption process could be examined. To 
investigate the influence of electrostatic interactions in between the protein molecules as well 
as between the protein and the sorbent, the adsorption was additionally determined at two 
different ionic strength levels of 40 mM and 170 mM. 
3.1.1 Adsorption to Borosilicate Glass Vials 
At first, the adsorption behavior of IgG1, the F(ab’)2 and the Fc fragment on borosilicate glass 
vials is presented. All proteins showed the same pH- and ionic strength-dependent adsorption 
behavior at the tested conditions (Figure IV-2a). Maximum adsorption was found at pH 4.0, 
decreasing via pH 7.2 toward pH 8.6. Increasing the ionic strength from 40 mM to 170 mM 
led to enhanced adsorption at pH 4.0, whereas adsorption was reduced at pH 7.2 and 8.6. 
Compared to IgG1 and Fc, these changes were more pronounced for F(ab’)2. At most of the 
conditions, the adsorbed amount of the fragments was lower than of the full IgG1. The mass 
of adsorbed Fc was remarkably high and exceeded the F(ab’)2 adsorption at pH 7.2 and 8.6. 
At pH 8.6 and 170 mM ionic strength, F(ab’)2 adsorption could not be quantified anymore. 
Adsorption maxima at pH values below the pI were reported for several proteins [6, 21]. 
Isoelectric focussing showed 6 to 7 characteristic isoforms in the pH range from about 7.6 to 
8.2 for IgG1 (Figure IV-1b). The F(ab’)2 fragment exhibited 4 to 5 distinct bands in a similar 
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pH range of about 7.6 to 8.3, whereas for the Fc fragment, a rather broad distribution with 
several less defined bands between about pH 6.5 and 7.6 was detected (Figure IV-1b). IgG1 
and F(ab’)2 were thus positively charged at pH 4.0 and 7.2 and exhibited a negative net charge 
at pH 8.6 whereas a fraction of the Fc fragments exhibited a negative net charge already at 
pH 7.2. Charge heterogeneity may originate from differences in glycosylation, glutamine and 
asparagine deamidation [22], the presence or absence of C-terminal lysins [23] or the 
formation of pyroglutamate from N-terminal heavy chain glutamine [24]. Similar to our 
finding, a comparable pI of the F(ab’)2 fragment and IgG1 and a more acidic pI of the Fc 
fragment was reported for IgG1B [13]. If Fc and F(ab’)2 fragment exhibit a lower and higher 
pI than the full antibody, respectively, the full antibody carries a dipole moment at its pI [25]. 
A dipole moment of our antibody can thus be expected at pH values between the pI of the Fc 
and the F(ab’)2 fragment. Borosilicate glass exhibits a pI of about pH 2.3 [6] so that the 
hydrophilic glass surface was negatively charged in the whole investigated pH range. 
 (a)       (b) 
       
Figure IV-1: (a) SDS-PAGE of IgG1, Fc and F(ab’)2 fragment separated on a 7% tris-
acetate gel. Marker bands: (I) 400 kDa, (II) 200 kDa, (III) 116 kDa, (IV) 97 kDa, 
(V) 66 kDa, (VI) 55 kDa, (VII) 36 kDa, (VIII) 31 kDa, (IX) 21 kDa. (b) Isoelectric 
focusing gel in the pH range of 6-9 for the determination of the isoelectric point (IEP) of 
IgG1, F(ab’)2 and Fc fragment. Marker bands can be assigned to the pH values of 
(I) 10.7, (II) 9.5, (III) 8.3, (IV) 8.0, (V) 7.8, (VI) 7.4, (VII) 6.9 and (VIII) 6.0. 
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At pH 4, IgG1 and both fragments exhibited a strong positive net charge and were 
electrostatically attracted toward the negatively charged glass surface. At the same time, the 
strong intermolecular repulsion opposed adsorption. This repulsion, but also the electrostatic 
attraction toward the sorbent surface may be reduced at higher salt concentrations [26]. 
Higher adsorbed amounts at an ionic strength of 170 mM compared to 40 mM reflected a 
prevalent reduction of intermolecular repulsive forces by ions in our experiment (Figure 
IV-2a). 
(a) 
 
(b) 
 
Figure IV-2: Adsorption of IgG1, Fc and F(ab’)2 fragment to type I borosilicate glass 
vials (a) and siliconized glass vials (b) at different pH and ionic strength; incubation time 
24 h at 25 °C; solutions contained equimolar protein concentration in 10 mM phosphate 
buffer at 40 mM (grey bars) or 170 mM (striped bars) ionic strength (n=2). Adsorbed 
amounts of samples labeled with star (*) could not be quantified any more. 
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With increasing pH toward 7.2 and 8.6, the positive net charge of the proteins decreased. At 
pH 7.2, the pI range of the Fc fragment was reached so that a fraction of the Fc molecules 
already exhibited no net charge or a negative net charge. Despite the expected electrostatic 
repulsion between the negatively charged fragments and the negatively charged sorbent 
surface, considerable adsorption was found at low ionic strength. In this regard, the net charge 
as the sum of positive and negative charges of a molecule and thus the amino acid 
composition of the fragment has to be considered. About 95% of the amino acid sequence in 
human IgG1 antibodies are conserved [24]. The human IgG1 CH2 and CH3 regions, which 
are part of the Fc fragment, contain together 15 glutamate, 10 aspartate and 5 cysteine 
residues per heavy chain, but also 6 arginine, 6 histidine and 19 lysine residues. 99.9% of the 
lysine side chains and about 20% of the histidine side chains are still positively charged at 
pH 7.2 (Table IV-1) so that the Fc fragment is expected to carry a considerable number of 
positive charges at this pH. It was further emphasized, that the distribution of charges rather 
than the average net charge of a protein influences adsorption [27] and intermolecular 
interactions [28]. We therefore ascribe the adsorption of the Fc fragment to the electrostatic 
attraction toward the sorbent surface via positively charged protein patches. This assumption 
was underlined by the reduced adsorbed amounts at a higher ionic strength of 170 mM, which 
indicated a screening of electrostatic attractive forces by ions. Furthermore, weak 
hydrophobic interactions between the protein molecules and the sorbent supposedly 
contributed to adsorption. IgG1 and F(ab’)2 both exhibited a positive net charge at pH 7.2 and 
were thus electrostatically attracted toward the borosilicate glass. 
Slightly above the pI range of IgG1 and F(ab’)2 at pH 8.6, the full antibody and both 
fragments exhibited a slightly negative net charge. Due to the intermolecular repulsion and 
Table IV-1: Average pKa of side chains of amino acids in folded proteins according to 
[29] and percentage of acidic form at pH 4.0, 7.2 and 8.6. 
  Percentage of acidic form  
 Amino acid pKa [29] pH 4.0 pH 7.2 pH 8.6  
 Lysine 10.5 ± 1.1 100.0 99.9 98.7  
 Tyrosine 10.3 ± 1.2 100.0 99.9 98.0  
 Cysteine 6.8 ± 2.7 99.8 28.4 1.5  
 Histidine 6.6 ± 1.0 99.7 20.0 1.0  
 Glutamate 4.2 ± 0.9 61.3 0.1 0.0  
 Aspartate 3.5 ± 1.2 24.0 0.0 0.0  
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the electrostatic repulsion between the negatively charged protein and the sorbent surface, 
reduced adsorbed amounts could be expected. However, Fc adsorption was only marginally 
lower than at pH 7.2. This may be ascribed to the almost unchanged protonation degree of 
lysine compared to pH 7.2 (Table IV-1), enabling electrostatic attraction of the molecules 
toward the sorbent via positively charged protein patches. Furthermore, a contribution of 
hydrophobic interactions to adsorption of the molecules can be assumed. Compared to IgG1 
and Fc, the adsorbed amount of F(ab’)2 was very low at pH 8.6 which indicated a very weak 
electrostatic and hydrophobic attraction of this fragment toward the surface. Due to the 
variable part of the F(ab’)2 fragment, larger differences in sequence between different IgG1 
antibodies may occur. Several lysine residues in the CH1 region of human IgG1 imply also 
for this fragment the possibility to adsorb via positively charged protein patches to the 
negatively charged glass surface. However, these positive charges may be buried in the 
interior of the molecule or outweighed by negative charges in the variable part. 
Our IgG1 and F(ab’)2 exhibited a comparable pI and adsorption trend which has been 
similarly described in literature for other antibodies and their fragments on different surfaces 
[30]. In our experiment, also the Fc fragment showed basically the same adsorption behavior. 
In contrast, Buijs et al. found a marginal pH- and ionic strength-dependence of Fc adsorption 
to silica and methylated silica and ascribed it to the low influence of protein-sorbent 
interactions on Fc adsorption [13]. Lower pH-effects on the adsorption of Fc than of F(ab’) in 
a competitive adsorption were further ascribed to the dominance of hydrophobic forces for Fc 
adsorption [31]. 
On borosilicate glass vials, Fc adsorption was by trend slightly higher at pH 7.2 and 8.6 and 
slightly less dependent on ionic strength than adsorption of F(ab’)2. Therefore it may be 
hypothesized that IgG1 adsorption is driven rather by the Fc fragment, especially at slightly 
basic pH values. Adsorption of IgG with the Fc fragment was also proposed by Nagaoka for a 
hydrophobic surface [12]. In addition, Buijs determined a much higher Gibbs energy barrier 
for the adsorption of F(ab’)2 than for IgG on silica at some conditions and suggested that the 
IgG molecule attaches preferentially with the Fc fragment onto the surface [13]. Furthermore 
it was shown that membrane-bound IgG was able to bind antigen from solution [32, 33]. In 
contrast, Vermeer et al. suggested a preferential adsorption of IgG2b to hydrophobic Teflon 
particles with the F(ab’) fragments which exhibited a higher hydrophobicity [15]. We 
considered this orientation rather unlikely for the very hydrophilic glass, because lower 
adsorbed amounts were found for the F(ab’)2 fragment than for the Fc fragment at pH 7.2 
and 8.6. 
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3.1.2 Adsorption to Siliconized Glass Vials 
Similar to borosilicate glass vials, almost no difference between the fragments and IgG1 in the 
pH- and ionic strength-dependent adsorption behavior was observed on siliconized glass vials. 
Again, maximum adsorption was found at pH 4.0 with lower, rather similar adsorbed amounts 
at pH 7.2 and pH 8.6 (Figure IV-2b). Increasing the ionic strength from 40 mM to 170 mM 
led to increased adsorption at pH 4.0 for all protein molecules, but was most pronounced for 
F(ab’)2. This effect was marginal at pH 7.2 and 8.6. 
Siliconized glass shows a pI of about pH 3.4 (Chapter II3.1.1) and thus exhibits a negative net 
charge over the tested pH range of 4.0 to 8.6. In contrast to the hydrophilic glass surface, the 
siliconized glass surface allows strong hydrophobic interactions with the proteins in addition 
to electrostatic interactions. This was demonstrated by the largely higher adsorbed amounts of 
IgG1 and the fragments on the siliconized surface compared to borosilicate glass, especially at 
pH 7.2 and 8.6. The minor importance of electrostatic interactions for adsorption at these 
higher pH values was underlined by the low effect of changing ionic strength on the adsorbed 
amount. Similarly, Buijs et al. stated that the adsorption of IgG and its F(ab’)2 fragment to 
hydrophobic latices is mainly governed by hydrophobic interactions but is still influenced by 
electrostatic forces [30]. At pH 7.2 and 8.6, the adsorbed amount of Fc and F(ab’)2 did not 
differ noticeably, so that no conclusion about the preferential orientation of adsorbed IgG1 on 
this basis could be drawn. In contrast, the strong increase in IgG1 adsorption at pH 4.0 with 
higher ionic strength was also observed for the F(ab’)2 fragment but was only marginal for the 
Fc part. In the following section, the possible steric reasons for the similarity in adsorbed 
amounts of Fc, F(ab’)2 and IgG1 on siliconized vials will be discussed. 
 Simultaneous Adsorption of F(ab’)2/ Fc Fragments and Orientation 3.2
Considerations 
Besides the separate adsorption of the fragments, the total protein adsorption from solutions 
containing Fc and F(ab’)2 fragments in equimolar concentration was investigated. Overall, the 
adsorption of the Fc / F(ab’)2 mixtures to siliconized and bare borosilicate glass vials showed 
a similar dependency on pH and ionic strength as the full antibody and the individual 
fragments (Figure IV-3a, b). However, on borosilicate glass vials, the adsorbed protein mass 
from the Fc / F(ab’)2 mixture was consistently lower than that of the full IgG1 (Figure IV-3a), 
whereas on siliconized glass vials the adsorption of the mixture was in some cases almost the 
same or even higher (Figure IV-3b). 
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Besides the interplay of attractive and repulsive forces between protein and sorbent and in 
between the protein molecules, the adsorbed amount of protein on a surface is also related to 
the orientation of the molecules on the surface. As shown in Figure IV-4, the maximum 
surface coverage of IgG1 and its fragments at different surface conformations can be 
calculated in approximation from the dimensions of crystallized F(ab’) and Fc [30], assuming 
a 100% coverage of the sorbent surface area with protein. 
According to the calculated values in Figure IV-4, adsorbed amounts of IgG1 higher than 
approximately 2.9 mg/m² require an end-on orientation of the molecules (orientation A, B) or 
multilayer coverage. On borosilicate glass vials this applies at pH 4.0 as well as at 
pH 7.2 / 40 mM ionic strength, whereas at the other formulation conditions, also a side-on 
orientation (Figure IV-4, orientation D, E) of the molecules was possible. This means that at 
conditions of high electrostatic attraction between IgG1 and the surface but also high 
intermolecular repulsion, a small contact area between proteins and sorbent, as obtained in an 
end-on orientation, was sufficient for adsorption. At less attractive conditions, a side-on 
orientation of the molecules may be required to increase the interaction with the surface. 
For adsorption of isolated F(ab’)2, at pH 7.2 and 8.6 all surface orientations were possible 
based on the adsorbed amount. At pH 4.0 / 40 mM ionic strength and under the precondition 
of monolayer coverage, the measured adsorbed amount required F(ab’)2 adsorption in a rather 
collapsed conformation (orientation F) if adsorption in a comparable conformation as in the 
full antibody is assumed. Due to the strong inter- and intramolecular repulsion at this 
(a) (b) 
  
Figure IV-3: Total adsorbed protein amount from mixtures of F(ab’)2 and Fc fragment 
to type I borosilicate glass vials (a) and siliconized glass vials (b) at different pH and 
ionic strength (grey bars). Adsorbed amounts of IgG1 are depicted as reference ( );
incubation time 24 h at 25 °C; solutions contained equal molar concentration of Fc and 
(Fab’)2 in 10 mM phosphate buffer with 40 mM or 170 mM ionic strength (n=2). 
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formulation condition, however, (partial) adsorption of the molecules in a stretched 
orientation (orientation H) or in multilayers seems more likely. This stretched conformation H 
was suggested by Buijs et al. for F(ab’)2 at increased protein charge density when the F(ab’) 
units electrostatically repel each other [30]. At 170 mM ionic strength, the molecules 
supposedly adsorbed in a stretched orientation (H) or formed multilayers. For the Fc 
fragment, adsorption in all theoretical orientations was considered possible based on the 
adsorbed amount. 
Assuming an exclusively flat-on adsorption of the antibody (orientation E) and a comparable 
orientation of the isolated fragments (orientations I and K), adsorbed amounts of 
< 1.8-2 mg/m² for all proteins were required which applied at pH 7.2 and 8.6 at 170 mM ionic 
strength. In general, the total protein adsorption from Fc / F(ab’)2 mixtures did not reach the 
IgG1 adsorption level (Figure IV-3a) which might be ascribed to different possible packing 
densities or different molecular orientations of the proteins. The orientation of Fc and F(ab’)2 
 
Figure IV-4: Surface conformations and calculated adsorbed amount Γ in mg/m² for 
adsorbed IgG1 (A-E), F(ab’)2 fragment (F-I) and Fc fragment (J, K). Calculated 
adsorbed amounts and schematic drawing of orientations A-C and E-I are reproduced 
and adapted from [30]. Side-on orientation D with one F(ab’) fragment directed toward 
the solution was adapted from Wiseman & Frank [34]. Calculations of adsorbed 
amounts of orientations D, J and K are based on the dimensions of crystallized F(ab’) 
(8.2 x 5.0 x 3.8 nm³) and Fc (7.0 x 6.3 x 3.1 nm³) as used by Buijs et al. [30], applying a 
molecular weight of 50, 100 and 150 kDa for Fc, F(ab’)2 and IgG1. Calculations are 
based on the assumption of a 100% possible surface coverage with protein. 
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in the simultaneous adsorption will not be considered further as this will depend on the 
fragment ratio on the surface which cannot be hypothesized. 
On siliconized glass vials, at pH 4.0 the antibody molecules can be assumed to adsorb in an 
end-on orientation as well. The rather high IgG1 adsorption of 2.6-3.3 mg/m² (Figure IV-2b) 
at pH 7.2 and 8.6 allowed an end-on adsorption but also a side-on adsorption of IgG1 with 
one F(ab’) pointing toward the solution (orientation D as suggested by [34]) for the majority 
of the molecules. Considering the similar adsorbed amounts of IgG1, Fc and F(ab’)2 at pH 7.2 
and 8.6, adsorption in a certain conformation which is favored on the hydrophobic siliconized 
glass surface may be speculated. Recent publications proposed the adsorption of IgG to 
hydrophobic membranes with the hinge region and a part of the Fc fragment [7, 16]. Sun et al. 
concluded this from the ability of membrane-bound IgG to bind Protein A and antigen, and 
from the antigen binding by separated, adsorbed F(ab’)2 fragment [16]. An adsorption of Fc, 
F(ab’)2 and the antibody with the hinge region, as proposed in literature, may actually explain 
the similar adsorbed amounts of the proteins as observed on siliconized vials. At pH 7.2 and 
8.6, the adsorbed amounts of Fc and F(ab’)2 between 2.0 and 3.0 mg/m² theoretically allow (at 
least largely) adsorption of both fragments with the hinge region. Although adsorption of 
IgG1 at these pH values exclusively via the hinge region was not possible, a mix of initially 
adsorbed IgG1 molecules preferentially with their middle region and further end-on 
adsorption may be considered. An initial flat-on adsorption of IgG1 to a hydrophobic 
membrane and further adsorption in various vertical surface orientations with increasing 
surface coverage was also suggested by Wiseman & Frank [34]. Thus it may be concluded, 
that on siliconized vials a preferential adsorption with the hinge region of the antibody is an 
option for the orientation of weakly charged IgG1 on the surface. 
4 CONCLUSION 
In this study the adsorption behavior of IgG1, the F(ab’)2 and the Fc fragment on borosilicate 
glass vials and siliconized glass vials was investigated in dependence of pH and ionic 
strength. On both vial qualities, the adsorption maxima of the different proteins were found at 
an acidic pH value due to strong attractive electrostatic interactions between the protein and 
the negatively charged sorbent. On borosilicate glass, a strong dependence of adsorption on 
pH and ionic strength was observed. In contrast, the contribution of hydrophobic interactions 
to the adsorption process on siliconized vials led to quite high adsorbed amounts even when 
the proteins exhibited only a weak or neutral net charge. On both surfaces, adsorption of the 
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Fc fragment could be observed even at electrostatic repulsive conditions between protein and 
sorbent surface. Different molecular orientations of IgG1 were considered in dependence of 
the adsorbed amounts measured on borosilicate glass and siliconized glass. Protein net charge 
and surface charge distribution are specific properties of each individual antibody. The 
obvious importance of these parameters for adsorption in our experiments thus implies that 
found adsorption trends cannot be simply transferred to other antibodies or are easily 
predictable just from pI determination. 
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Chapter V  
 
Summary of the Thesis 
 
Adsorption of therapeutic proteins to pharmaceutical packaging materials leads to several 
problems such as a loss in protein concentration and potential protein aggregation. These and 
the arising consequences, e. g. increased costs and immunogenic risks, were presented in 
detail in the general introduction. The two major possibilities to avoid protein adsorption are 
the adaption of the formulation and the selection of an appropriate packaging material, 
potentially with a suitable coating. This thesis focuses on the protein adsorption to coated 
glass vials, especially siliconized glass vials as a commercial, widely used container, but also 
to vials coated with protein repellent polyglycerol. Two IgG1 antibodies as therapeutically 
relevant proteins and lysozyme as a model protein were used for the adsorption studies and 
their adsorption behavior to the coated vials and bare glass vials was investigated. 
In chapter II, the influence of various formulation parameters on the adsorption of a 
monoclonal IgG1 antibody to siliconized vials and glass vials was investigated. Maximum 
adsorption at an acidic pH value between the isoelectric points of the sorbent surface and the 
protein demonstrated the importance of attractive electrostatic conditions for the adsorbed 
amount. Calculation of the charge transfer between the protein-sorbent interface and the 
surrounding solution showed a correlation between the minimum ion uptake into the interface 
and the pH of maximum adsorption. A second adsorption maximum around the pI of IgG1 
was ascribed to hydrophobic protein-sorbent interactions. In addition, adsorption in presence 
of common excipients such as nonionic surfactants, sugars and polyols, as well as at different 
ionic strength was investigated. Both tested surfactants polysorbate 80 and poloxamer 188 
efficiently reduced IgG1 adsorption to siliconized vials. Long-term storage of IgG1 at 
different pH values and temperatures revealed a correlation between the stability of the 
protein formulation and the adsorbed amount. For lysozyme, maximum adsorption close to 
the pI of the protein demonstrated the prevalent importance of the intermolecular electrostatic 
repulsion for the adsorbed amount of this protein. 
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Protein adsorption to new, polyglycerol coated vials was investigated in chapter III. All 
coatings efficiently suppressed IgG1 adsorption to the vials at different pH values and ionic 
strength. Especially the hyperbranched, non-methoxylated polyglycerol (HPG(OH))-coated 
vials showed excellent protein resistant properties even after long-time storage with protein 
solution and after sterilization. Polyglycerol coated vials are thus a promising candidate for 
the packaging of biopharmaceuticals. 
Antibodies are molecules with different subunits which may influence the adsorption behavior 
of the whole molecule. Therefore, the IgG1 antibody was cleaved and the adsorption behavior 
of the isolated Fc and F(ab’)2 fragments was investigated in siliconized and non-coated glass 
vials in chapter IV. The influence of electrostatic and hydrophobic interactions on adsorption 
was evaluated by quantifying the adsorbed amount at different pH and ionic strength. On 
glass vials, especially electrostatic interactions influenced the adsorption pattern of IgG1 and 
the fragments, whereas hydrophobic interactions dominated the adsorption behavior on 
siliconized vials when the molecules were weakly charged. Possible molecular orientations 
were aligned with the adsorbed amount and an end-on adsorption for highly charged IgG1 
was suggested. For siliconized vials, adsorption with the middle region of the antibody at 
basic pH conditions was hypothesized. 
In summary, the described investigations on protein adsorption to various coated glass 
surfaces demonstrated the influence of the formulation composition, the protein and sorbent 
charge and the protein stability on the adsorption behavior. Especially the pH value and the 
ionic strength were found to affect the adsorbed amount. The study shows that by choosing 
appropriate excipients or new coatings such as polyglycerols, the formulation scientist can 
effectively minimize the unspecific protein adsorption to packaging materials. Finally, this 
thesis may encourage further investigations on the understanding and prevention of protein 
adsorption phenomena and the development of new protein repellent packaging materials. 
